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ABSTRACT
Hydrogels have been widely investigated for their versatility in biomedical
applications such as tissue engineering scaffolds and minimally invasive vehicles for sitespecific delivery of bioactive molecules. Hybrid hydrogels combine the strengths of
intrinsic bioactivity from naturally derived materials and superior control over network
physical and chemical properties from synthetic materials. The most prominent approach
in three-dimensional (3D) hybrid matrices is the use of MMP-sensitive peptides derived
from native extracellular matrix molecules to crosslink synthetic polymers. These
peptide-based techniques have several limitations such as high cost, limited mechanical
properties, and reduced degradation kinetics that limit the network crosslinking density
and mechanical properties. This led us to develop a novel hydrid hydrogel system, in situ
photopolymerizable, degradable, poly(ethylene glycol) (PEG) diacrylate / hyaluronic acid
(HA) semi-interpenetrating networks (semi-IPNs).
In the first set of studies, we determined the effects of network composition
(PEGdA and HA molecular weight and concentration) on 3D cell spreading and
identified polymerization-induced phase separation as the underlying mechanism
responsible for the ability of PEGdA/HA semi-IPNs to support 3D cell spreading. SemiIPNs with optimal network composition including a blend of three different PEGdA
providing improved degradation kinetics demonstrated the ability to support long-term
fibroblast cell spreading, migration, and network formation. In addition, the selected
semi-IPNs were also found to possess elastic moduli significantly higher than most
alternative hybrid hydrogels and within the range reported as optimal for osteogenic
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differentiation of mesenchymal stem cells. In second study, we investigated the ability of
the semi-IPNs to support hMSC differentiation as a preliminary study towards bone
tissue engineering application. Gene expression, alkaline phosphatase activity,
histological analysis, and calcium quantification demonstrated the semi-IPN’s ability to
support osteogenic differentiation over 35 days of culture. In the final study, we
incorporated poly-L-lactic acid (PLLA) nanospheres in semi-IPNs to test the hypothesis
that provision of hydrophobic domains capable of supporting higher protein adsorption
than the PEG network could increase extracellular matrix accumulation. Significantly
increased collagen deposition was observed in histological sections and by quantitative
analysis.
Overall, the results of this work suggest that PEGdA / HA semi-IPNs and their
composite derivatives offer potential as a hybrid matrices for therapeutic cell
transplantation. In the future, the biofunctionality of these hybrid networks can be further
enhanced by inclusion of growth factors or biochemicals.
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CHAPTER ONE
INTRODUCTION

1.1 Cell Therapy and Tissue Engineering
The early attempts to repair defective tissues or organs in regenerative medicine
were to simply transplant (inject) somatic cells into a lesion area, but typically this
approach led to little success [1,2]. Transplanted cells may be perfused out or die at the
early stage of transplantation [3]. Cell death occurs in the first few days posttransplantation, caused by the combination of ischemia (a restriction in blood supply to
tissues) and inflammation. Also the lack of matrix can induce cell death and this is
mediated by the anoikis signaling pathway [1,4]. The most widely used tissue
engineering strategy to avoid initial cell death and increase cell retention is to combine
cells and biologically active molecules together within the tissue engineering scaffold [5]
which allows the creation of biomimetic three-dimensional (3D) microenvironments that
provide biomolecular cues that direct cellular function, guiding the spatially and
temporally complex multicellular processes of tissue formation and regeneration [6].
Cellular encapsulation in scaffold matrices helps successful cell transplantation by
preventing the anoikis signaling pathway and prohibiting immediate cell perfusion while
permitting the diffusion of gas, nutrients, wastes and bioactive molecules by fine-tuning
the pore sizes [7]. Additionally, advanced 3D microenvironment systems are needed to
better understand cellular activities using in vitro models in order to later realize their
potential in vivo since there are significant differences in cellular activities, especially in
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stem cell differentiation between two-dimensional (2D) and 3D culture conditions [8–
11].

1.2 Monolayer vs. Three Dimensional (3D) Culture
Cells in monolayer culture (2D surface) develop an apical/basal polarity with one
side in contact with the culture substrate and the other exposed to culture media that is
non-physiological for most cell types. Additionally, cell-cell contact only occurs at the
periphery of cells spread in 2D monolayers. However, in the in vivo (3D) environment,
cells interact with neighboring cells as well as the ECM [12]. Mass transport is also
different in 3D culture from 2D monolayer culture. Soluble factors are not diffusion
limited in 2D culture, whereas diffusion gradients play a key role in transport of
biochemical factors produced from native ECM [13].
Cell-matrix interactions in 3D environments reflect a narrowed integrin usage
(more dependency on α5 integrin) and enhanced biological activity relative to monolayer
culture such as cell adhesion (by a factor of 6) [10]. These differences in morphology
have significant impacts on cell function. Breast epithelial cells exhibited a tumoral trend
when assayed in 2D culture, while regressed to normal state upon transferal to 3D models
which resembled their natural niche [14]. In the same way, increased chondrogenesis has
been reported in ESCs cultured as 3D embryoid bodies when compared to the monolayer
culture [15]. Morphogenesis, migration, and proliferation of cells in 3D culture are
restricted by matrix, whereas 2D surface offer no restriction to cell migration as shown in
Figure 1.1 [11]. Cell interaction with microenvironment (ECM) is more important factor
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in directing cell phenotype than its genotype [14,16]. Thus, cells should be evaluated in
the context of the ECM [11].
(A)

(B)

Figure 1.1 Comparison between monolayer (2D) and 3D interactions. Cells placed in 2D
culture (A) become polarized and orient in a specific direction that confines their
interactions with adsorbed proteins (yellow fiber) through integrin binding (brown)
receptors to specific ligands (green) located on specific regions of the cell. This
polarization also limits their interactions with media components and soluble factors
(orange receptors and red ligands) on the opposite side of the cell, while confining cellcell interactions and migration to a plane. In contrast, 3-D culture (B) conditions enable
isotropic interactions with extracellular biomolecules and chemical factors through
receptor-ligand binding on all surfaces of the cell as well as isotropic cell-cell interactions
and migration [17].
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1.3 Native Extracellular Matrix (ECM)
In order to achieve successful tissue regeneration, 3D cell transplantation
scaffolds must mimic natural niches closely. This requires a comprehensive insight into
the complex and dynamic nature of the extracellular matrix (ECM) and cells within the
matrix [11]. It is a hierarchically organized structure composed of a three-dimensional
array of protein fibers and filaments embedded in a hydrated gelatinous network of
polysaccharide chains of glycosaminoglycans (GAGs).
GAGs are hydrophilic, unbranched, negatively charged polysaccharide chains that
form stiff and highly extended conformations. Their negative charges attract counter ions
inducing an osmotic effect that enables the matrix to occupy large volumes of water.
Most GAGs are sulfated, covalently linked to protein via linker proteins and are
synthesized intra-cellularly and released via exocytosis. The four main groups of GAGs
are hyaluronic acid, chondroitin sulfate, keratin sulfate, and heparin sulfate. The
exception among the GAGs is hyaluronic acid which is the simplest GAG molecule and
is released directly from the cell surface by an enzyme complex embedded in the plasma
membrane, not sulfated, and not covalently linked to proteins. HA is found in most
mammalian tissue and fluid, especially prevalent during embryogenesis and wound
healing where its presence modulates cell migration in the extracellular space by
controlling the level of hydration in tissues. Proteins with covalently attached GAGs
constitute proteoglycans (PGs) which fill the majority of the ECM interstitial space
within the tissue in the form of hydrated gel with varying porosity and charge density,
allowing them to regulate the molecular diffusion of molecules and cell migration [18–
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22]. From this unique nature (hydrated state and glycosylated protein filaments), PGs
associated with collagen fibers provide the ECM with mechanical buffering which resists
compressive stresses. Additionally, PGs bind a variety of growth factors, acting as a
storage reservoir from which they can be enzymatically released by cellular proteolytic
activity [20,23,24].
The fibrous proteins of the ECM can be categorized as structural (i.e., collagen
and elastin) and adhesive (i.e., fibronectin and laminin) types and their fibrous forms
provide mechanical integrity of ECM. Collagen is the most abundant protein in the ECM
(up to 30% total protein mass) which is secreted locally by cells, for instance, fibroblasts
in most connective tissues, osteoblasts in bone, and chondrocytes in cartilage [19,20].
Various chemically distinct forms of collagen (28 types in vertebrates identified to date)
exist and they assemble into different supramolecular structures, mostly fibrils and
network type, to have functional diversity [25,26]. Fibrous collagens (type I, II, and III)
form the backbone of the collagen fibril bundles within the interstitial tissue stroma.
Collagen type IV is a network-forming collagen resulting in a mesh-like lattice which
constitutes a major portion of the basal lamina. Cells bind to this basal lamina via indirect
binding to laminin adhesive proteins [19,26,27]. Another major fibrous protein is elastin
and its fiber form provides recoil to tissues that undergoes repeated stretch. Elastin
precursor (tropoelastin) molecules assemble to form fibers via covalent bonding of lysine
residues between individual tropoelastin molecules, which renders the ECM elastic.
Collagen associates with elastin and forms interwoven fibrous protein structures. These
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structures provide the ECM with tensile strength and limit elastin stretch by tight
association with collagen fibrils [20,28].
Fibronectin (FN) is adhesive protein in the ECM consisting of two subunits and
plays crucial role in cell attachment and ECM organization with several binding sites to
other FN dimers, to collagen, to heparin and to integrin receptors. It can be stretched
several times over its resting length by neighboring cellular traction force [29]. This
traction force-dependent nfolding of FN exposes cryptic integrin-binding sites recognized
by integrins on cell surface, resulting in integrin-ECM ligand (α5β1) adhesion binding
and also promoting FN-fibril assembly. Integrin receptors on the cell surface bind to a
fibronectin domain containing the well-known tripeptide adhesion sequence arginineglycine-aspartic acid (RGD) and the neighboring synergy site while other distinct protein
domains bind to collagen and heparin [30]. Additional binding sites (IIICS) within FN
contains peptide sequence REDV and LDV which mediate specific cell type binding such
as neural cells and lymphocytes. FN is also a regulating factor for cell migration timing
during development [21,31]. As mentioned above, another adhesive protein, laminin is
associated with basement membranes. Multiple peptide sequences such as RGD, YIGSR,
IKVAV, heparin and collagen IV binding regions have been identified in laminin. These
insoluble, adhesive type proteins are deposited on this backbone of fibrous proteins
[18,30]. Integrin-ECM ligand binding interactions provide communication between the
intracellular and extracellular environments which have been shown to play critical roles
in cell shape, migration, proliferation and differentiation [28,32].
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The ECM is a dynamic cellular microenvironment that undergoes constant
remodeling (i.e. assembly and degradation of its constituents) by cells particularly during
the normal physiological process of development, differentiation, and wound healing.
Also, the mechanical properties and biochemical composition of ECM varies
considerably from tissue to tissue (e.g. lungs versus skin versus bone), locally within one
tissue (e.g. renal cortex versus renal medulla), as well as from one physiological state to
another (normal versus cancerous) [18,20,30]. Cells embedded within ECM have to
change from an adhesive phenotype to a migratory phenotype prior to their migration
within its three-dimensional structure [33]. During cell migration, cells secrete proteolytic
enzymes (proteases) that cleave a variety of ECM substrates to break down physical
barriers that inhibit cell locomotion. The most prominent example of this protease is
matrix metalloproteinase (MMP) family which consists of 23 structurally related
endopeptidases in humans. There are four different classes of MMPs and they degrade
different types of ECM molecules or activate other types of MMPs [34]. Most MMPs are
secreted in latent form as pro-enzymes and later activated by the displacement of the prodomain by conformational change or proteolysis induced by the protease plasmin or by
other MMPs [35]. This MMP activity is counterbalanced by tissue inhibitors of
metalloproteinases (TIMPs) and the collagen crosslinking activity of lysyl oxidase (LOX)
and transglutaminases, which result in locally stiffened ECM [18,20,36,37]. During the
process of tissue remodeling, cells degrade the ECM with matrix metalloproteinase
(MMPs) as they deposit their own ECM components simultaneously. Both processes are
regulated by spatiotemporal integrin-mediated signaling pathways [30,38]. The ECM also
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contains growth factors (or cells producing growth factors) and other bioactive
molecules, as well as binding sites for cell-surface molecules exposed upon MMP
proteolysis [34,39]. Growth factors modulate cell growth and migration in the form of
controlled (release) feedback process for tissue homeostasis [40]. Cell-derived growth
factors may either be directly released for immediate signaling or embedded within the
matrix by binding proteins and later released by proteolytic degradation [32,39].
Cells in ECM sense and convert mechanical stimuli into biochemical signals via
cell-surface receptors [6]. Upon injury, recruited neighboring fibroblasts synthesize and
deposit large amounts of ECM proteins, resulting in stiffened matrix. The elevated
elasticity and deposited ECM induce trans-differentiation of fibroblasts or other tissue
residing cells into other cell types, for instance, epithelial cells to mesenchymal cell
transition or bone marrow derived mesenchymal stem cells into myofibroblast [41,42].
Also, remodeled ECM attracts the directional migration toward wound site [43]. Once
wound site is populated with healthy cells, feedback mechanisms are initiated to restore
tissue homeostasis and resolve fibrosis [20,41,42].

1.4 Hydrogel as Synthetic ECM
In tissue engineering, hydrogels are applied as space filling agents (bulking,
adhesion barrier, and biological glue), delivery vehicles for bioactive molecules, and
three-dimensional cell transplant scaffold as they can provide highly swollen 3D
environment enabling diffusive transport. Among these applications, hydrogels are
appealing scaffold materials as they are structurally similar to the ECM of many tissues,
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capable of being processed under cytocompatible conditions and delivered in a minimally
invasive manner [6,11,44,45].
Hydrogels can be categorized by the origin of macromere materials, naturallyderived hydrogels and synthetic hydrogels. Representative naturally-derived hydrogels
may be protein-based (collagen, gelatin, and fibrin) or polysaccharide-based (e.g.,
alginate, chitosan, hyaluronic acid, and dextran) [45]. Naturally-derived hydrogels
possess intrinsic bioactivities such as cell adhesion and biodgradability, which are
advantageous over synthetic hydrogels. For example, collagen and fibrin are clinically
well-established, FDA-approved materials for the healing of burns and chronic wounds,
and used as tissue sealants, respectively [6]. Especially, collagen is an attractive material
as it is the most abundant protein in mammalian tissues and can self-aggregate to form
stable fibers [46]. Also collagens can form fibers and scaffolds by introducing various
chemical linkers (i.e. glutaraldehyde, formaldehyde, carbodiimide) [47,48], by
crosslinking with physical treatments (i.e. UV irradiation, freeze-drying, heating) [47,49],
and by blending it with other polymers (i.e. HA, PLA, poly(glycolic acid) (PGA),
poly(lactic-coglycolic acid) (PLGA), chitosan, PEO) [47,48,50,51]. However, the use of
naturally derived hydrogels is often restricted due to concerns of potential
immunogenicity, pathogen transmission, difficulties in purification process as well as
poor mechanical properties [45,52]. In addition, their mechanical properties cannot be
readily manipulated, especially due to batch-batch variability and complexity.
Alternatively, synthetic hydrogels have advantages over naturally derived hydrogels,
such as greater and systematic control of material compositions and properties for the
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design of scaffolds for multiple tissue types [53,54]. Various non-immunogenic synthetic
materials have been tested as 3D hydrogel scaffolds for cell transplant application,
including poly(ethylene glycol) (PEG), poly(vinyl alcohol) (PVA), poly(acrylic acid)
(PAA), and various polypeptides. These hydrogels can be polymerized in situ under mild
physiological conditions [6,45,55].
The concept of hybrid hydrogel is to integrate the advantages of both naturally
derived and synthetic hydrogel. As synthetic hydrogels exhibit minimal or no intrinsic
bioactivities by themselves, they require the incorporation of biofunctional oligopeptide
sequences (e.g. RGD and MMP sensitive peptides), proteins (e.g. collagen), and other
biological molecules (e.g. heparin) from the native ECM to mimic natural ECM as hybrid
hydrogel concept [6,11,56–58]. With these biologically inert characteristics, synthetic
hydrogel can be a useful tool for 3D in vitro tissue culture scaffold to investigate cellular
response to ECM as it allows independent control of biomolecular and structural cues
from native ECM [6,59]. Among these synthetic components in hybrid hydrogel, PEGbased hydrogels have been widely investigated in tissue engineering as they have critical
properties such as easy structural modification and proven history of successful
application in many clinically-approved products [6,45]. In this dissertation research, we
will focus on the modification of PEG based hydrogel to mimic the native ECM and
improve its bioactivities over other PEG based hydrogel scaffolds.
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1.5 Design Strategy – Engineering ECM Cues
Successful 3D cell transplant scaffolds need to mimic critical aspects of the
natural ECM and must meet critical design criteria; biocompatibility, geling
(crosslinking) mechanism, mechanical properties (stiffness), degradation, and mass
transport. These properties or design variables are specified by the intended scaffold
application and environment into which the scaffold will be placed (target
microenvironment) as shown in Figure 1.2 [60]. Additionally, selection of the most
appropriate scaffolding material is crucial in a tissue-engineered construct. Synthesis of
the appropriate hydrogel scaffold materials is governed by the physical properties (gel
formation mechanism, mechanical characteristics, and degradation), the mass transport
properties, and the biological interaction requirements (biocompatibility and target
microenvironment) of each specific application [44].

Figure 1.2 Design considerations, factors dictating 3D tissue engineering scaffold [60]
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1.5.1 Biocompatibility
Biocompatibility is the first and most critical factor to consider prior to cell
encapsulation. The ideal way to encapsulate cells is in situ polymerization while the
hydrogel is forming for homogeneous distribution of cells and in the case of in vivo
applications, avoiding invasive surgical procedures. Scaffolds designed to encapsulate
cells must be capable of being gelled without damaging the cells and must be nontoxic to
the cells and the surrounding tissue after gelling. When naturally-derived materials such
as collagen are used, there should be no cross-species immunological response. Along
with naturally-derived polymers such as collagen, alginate, and fibrin; PEO and PEG are
currently used in many FDA-approved medical applications such as spinal sealant.
However, additional care should be taken post gelation as there are small toxic molecules
during hydrogel fabrication [44,60]. For example, unreacted maleimides in Michael-type
addition reactions are highly potent neurotoxins [61]. Photoinitiators, such as 2,2dimethoxy-2-phenyl-acetophenone used frequently in free-radical polymerization, can be
cytotoxic [62].
1.5.2 Mass transport
Most chemically crosslinked polymer hydrogels are dense network acting similar
to a porous structure [54], with a mesh sizes ranging nanometer to the order of tens of
nanometers allowing appropriate diffusion of nutrients and metabolites to and from the
encapsulated cells and surrounding tissue. In vivo, most cells exists within 100 µm of
capillary (one of exception is chondrocytes where no blood vessel exists in cartilage
tissue), and diffusion is the primary method of mass transport over this range [63].
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Additionally, diffusion governs mass transport within hydrogel networks due to their
nanoporous structure [44]. Crosslinking density and molecular weight of macromer
determines its nanoporous structure (mesh size) and resulting molecular weight cut-off of
solutes. Its porosity changes with matrix stiffness. The diffusion of small molecules is
more hindered in stiffer matrices [64–67].
1.5.3 Mechanism for hydrogel formation
Common polymer scaffold fabrication techniques use harsh conditions for live
cells such as high temperature, pH changes, and various organic solvents that can
denature proteins, which makes many fabrication techniques incompatible with live cell
encapsulation [60]. However many hydrogel formulations have been shown as injectable,
in vivo, in situ polymerizable 3D cell transplant scaffolds [68–71]. The success of this
approach depends on the ability to control both pre- and post-gelation properties
including gelation rates and liquid flow properties [44].
PEGs has linear and branched (multiarm or star) structures. The basic PEG
structure is PEG diol with two hydroxyl end groups, which converted into other
functional groups, such as methyloxyl, carboxyl, amine, thiol, azide, vinyl sulfone,
acetylene, and acrylate as listed in Figure 1.3 [45,68,72–74]. This functionalized PEG can
be further modified as thermally reversible hydrogel from block copolymer of PEG and
poly-L-lactic acid (PLLA) [75]. Degradable PEG based hydrogels can be formed by
incorporating either hydrolytically degradable poly(lactic acid) or enzyme specific
cleavage sequences of oligopeptides [73,74].
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Figure 1.3 Structures of linear PEG and four arm PEG with various functional end
groups [45]
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The two or more functional end groups can be used for crosslinking the network
and also for crosslinking bioactive peptides such as MMP sensitive and cell adhesion
peptides. They are also used for conjugating with biomolecules such as growth factors
[45]. The most commonly used polymerization methods for cell encapsulation
applications (in presence of cells under physiological conditions) are free radical
polymerization (Figure 1.4) [68,76–79], Michael-type addition (Figure 1.5) [80,81], and
thiol-ene reaction [82,83].
Free radical polymerization involves the formation of free radicals via
decomposition of an initiator by light, temperature, or redox reaction to yield primary
radical species [84]. These free radicals propagate through unsaturated functional groups
(carbon-carbon double bond) such as acrylate bonds on the PEG macromers and chain
polymerization occurs, resulting in covalently crosslinked polymer networks (Figure 1.4)
[85]. In these systems, complete gelation is achieved in relatively short times (seconds to
a few minutes). Photopolymerization of PEG diacrylate (PEGdA) hydrogels has been
extensively investigated in tissue engineering and regenerative medicine applications
since it offers advantages such as well-characterized reaction kinetics and facile in situ
polymerization in presence of cells with spatiotemporal control [86]. However, free
radicals can be transferred to proteins, affecting their bioactivity, or transferred to
biomolecules present in the cell membrane, affecting cell viability [60,87].
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(A)

(B)

Figure 1.4 Chemical structures of PEG macromer and its diacrylate derivatives (A) [85]
and synthesis of enzyme sensitive peptide (ESP) containing PEGdA by conjugating
acrylate-PEG-NHS with ESP diamine (ESP-2NH2) (B) [45]

16

Michael addition is a step-growth approach to crosslink PEG hydrogel network
under mild physiological condition in direct contact with tissues, cells and biological
molecules [45,85] using PEG or multiarm PEG macromers functionalized with acrylate,
maleimide, or vinyl sulfone group with dithiol monomers [88]. Michael-type addition
reactions occur between acrylates and thiols, and between maleimide and thiol groups
[28]. This reaction takes longer (hours) relative to the time of completion in free-radical
polymerization. This mechanism was extended to include cell adhesion motif and
enzymatic (MMP) degradation peptides as ECM mimics. For example, vinyl sulfone
functionalized four-arm PEG underwent two-step Michael addition reaction presented on
mono-cysteine adhesion peptides (RGD) and bis-cysteine MMP sensitive peptides for 3D
cell culture application (Figure 1.5) [89].
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Figure 1.5 A Michael type addition reaction between vinyl sulfone functionalized multiarm PEGs and mono-cysteine adhesion peptides (step 1, stoichiometric deficit) or biscysteine MMP sensitive peptides (step 2, stoichiometric balance) was used to form gels
from aqueous solutions in the presence of cells and cells locally interact with networks by
adhesion and protease secretion (step 3) [89].
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1.5.4 Engineering ECM cue – adhesion
Although many hydrogels are nontoxic and do not stimulate an immune response,
they are also biologically inert and do not facilitate cell adhesion. Additionally, ECM
proteins such as laminin, fibronectin, and vitronectin typically do not readily absorb to
the hydrogel due to their hydrophilic nature [90]. Therefore, the minimum requirement
for anchorage-dependent cells to survive on and within synthetic PEG-based scaffolds is
to render them cell-adhesive. In order to design highly specific adhesive surface, many
groups have covalently incorporated cell adhesion peptide sequences capable of binding
to cell receptors [73,90,91]. The most common peptide sequence is the arginine-glycineaspartic acid (Arg-Gly-Asp or RGD) sequence, derived from ECM proteins such as
fibronectin, laminin, vitronectin and collagen. While most cell types bind to the RGD
sequence, an additional region (IIICS) within fibronectin has been identified to contain
the peptide sequences, arginine–glutamic acid–aspartic acid–valine (REDV) that permit
the adhesion of specific cell types such as neural cells and lymphocytes. Other common
peptides from laminin include tyrosine–isoleucine–glycine–serine–arginine (YIGSR),
and isoleucine–lysine–valine–alanine–valine (IKVAV). The IKVAV peptide motif
involved in neurite growth, and a heparin and collagen IV binding region [90]. There are
two forms of RGD peptides, linear RGD and cyclic RGD (cRGD). cRGD peptide
sequence shows increased the affinity to integrin avβ3 and can enhance biological
activity up to 240 times in comparison with linear RGD analogues [92–94]. The
incorporation of cRGD peptides into the PEGDA hydrogels can better mimic the native
RGD loop structure and benefits the cell adhesion [45,95].
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1.5.5 Engineering ECM cue – degradation
The native ECM is dynamic matrix continuously remodeled for homeostasis and
tissue regeneration [19]. Therefore, the temporal and spatial variability of ECM
properties must be introduced into 3D culture models in order to simulate realistic
microenvironments. The incorporation of cell adhesion peptide sequences in PEG
hydrogels does not guarantee prolonged cell survival when cells are encapsulated within
3D scaffolds due to the nanometer mesh size of the crosslinked PEG network being less
than the average diameter of a cell. This small mesh size acts as a physical barrier to cell
migration and cell morphogenesis, resulting in a spherical cell morphology that is nonphysiological for many cell types [54,96]. Therefore, the successful design of scaffolds
for cell transplantation requires rendering the scaffolds degradable. Degradation allows
cell spreading and migration and can regulate the release of matrix-tethered biomolecules
that induce different cellular functions. Ideally, the rate of scaffold degradation should
mirror the rate of new tissue formation [97,98].
Degradation in hybrid hydrogel matrix can be achieved via ester bond hydrolysis,
enzymatic hydrolysis, or a combination of these mechanisms [60]. Synthetic hydrogels
can be designed to include degradable polymers within their network such as poly(lactic
acid) [99] or poly(caprolactone) [100] blocks in combination with PEG backbone for
hydrolytic degradation. Similarly, the scaffolds can be built by co-polymerization of
different ratios of degradable and non-degradable macromers [101]. The degradation rate
can be controlled by the number of incorporated hydrolytically labile bonds in the
hydrogel. The ratio between the number of two bonds offers predictable degradation
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profiles independent of cellular interactions as hydrolysis is an autocatalytic process
[102]. The degradation rate of hydrolytically labile gels (e.g. PEG-PLA copolymer) can
be manipulated by the composition of the material but not the environment [103].
However, hydrolytic degradation is not representative of the cell-mediated and dynamic
process of proteolysis that takes place within the native ECM. Instead, native ECM
derived molecules (i.e. collagen and fibrinogen) or protease sensitive peptide sequences
for degradation within synthetic hydrogel may present the site for enzymatic degradation
and constitutes hybrid hydrogel susceptible to cellular enzymatic degration [11].
Degradation of polymer is mediated by surface or bulk processes, or sometimes a
combination of the two. Hydrophilic polymers often exhibit bulk degradation process as
the rate of uptake of water is faster than the rate of conversion of polymer into water
soluble materials [104]. Enzymatic degradation site is usually localized to where
cells/enzymes are present while hydrolysis occurs throughout the bulk of the network
[11,60,85].
The rate of enzymatic degradation will depend both on the number of cleavage
sites in the polymer and the amount of available enzymes in the scaffold environment
[73,74]. Incorporation of peptide sequences susceptible to cleavage by cell-secreted
proteases (i.e., plasmin-sensitive or MMP sensitive sequences) into PEG hydrogels
manipulate gel degradation dynamically in response to cell-mediated events
[28,74,97,105–108]. However, these substrates do not degrade particularly fast which
may limit cellular infiltration within the scaffold [Chung S J Biomed Mater Res 2006]
and these peptides can also be cleaved by a variety of MMPs. Additionally, local pH and
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ionic strength, enzyme concentration, and temperature may affect enzyme-substrate
formation, resulting in degradation profile change [60]. Thus, recent strategies have
focused on enhancing proteolytic degradation of PEG hydrogels by using combinatorial
methods of peptide libraries consisting of MMP substrate sequences with increased
catalytic activity [28,109,110], by increasing the spatial presentation of these signaling
molecules within the hydrogel network [111], or by increasing the number of MMPsensitive peptides [112]. These hydrogel systems allow accelerated proteolysis, giving a
broader in vivo application.
1.5.6 Engineering ECM cue – matrix stiffness
Once the scaffold is produced and implanted, formation of tissues with desirable
properties relies on scaffold mechanical properties on both the macroscopic and the
microscopic level. Macroscopically, the scaffold must bear loads to provide structural
stability to the wound site until cells have produced their own functional ECM.
Microscopically, the scaffold must transmit mechanical loads to encapsulated cells and
maintain certain stiffness as cell growth and differentiation are dependent on these
mechanical inputs [113–116]. In the in vivo microenvironment, cellular level mechanical
forces consist of endogenous (generated by cells) and exogenous (applied to cells) forces.
Most of endogenous forces occur from cytoskeletal contractility [117,118]. Gravity and
tissue specific interactions such as endothelial cells exposed to pulsatile shear forces from
blood flow are examples of exogenous forces [119]. Additionally, it is well known that
cellular function is modulated by local matrix stiffness. In vivo, tissue modulus ranges
from Pa (liver tissue and adipose tissue) to GPa (bone) [59]. And this stiffness range is
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not static as it changes during physiological processes such as embryonic development,
tissue remodeling during wound healing, and in pathological responses like
tumorigenesis [120]. Individual cells can sense the stiffness change of surrounding ECM
to which they adhere and interact [121]. Various mechanotransducers in the cell convert
mechanical stimuli into chemical signals that regulate cell responses such as adhesion,
spreading, migration and proliferation [122]. Mechanochemical conversion is mediated
by ion channels [123], primary cilia [124], integrins [125], G-protein receptors [126],
cell–cell adhesions [127], and the cytoskeleton [128]. In particular, the integrin protein
family is a widely studied force transducer that serves as a mechanical linkage between
ECM and the cytoskeleton [129]. On the exterior of the cell, integrins bind ECM protein
ligands including collagen, laminin, and fibronectin, suggesting integrin receptors serves
as integrators of extracelluar signals [130]. Cells sense matrix stiffness by cellular
contractility and traction forces. Actin stress fibers are tensed by mysosin motors and
cytoskeletal contractility is transmitted to ECM as traction forces [131–133]. In response
to variation in substrate stiffness, cells alter cytoskeletal organization, cell-substrate
(focal) adhesions, and other processes important for regulating cell behaviors [134–137].
An increasing substrate stiffness results in increased cell-matrix (substrate) adhesion,
demonstrated by elongated adhesions (changes in cell shape) and increased tyrosine
phosphorylation of focal adhesion kinase (FAK) [138]. Califano showed that endothelial
cells on compliant substrates adopt an elongated spindle-shaped morphology, while those
on stiffer substrates exhibit more isotropic spreading, demonstrating that both cell area
and substrate stiffness are significant predictors of traction force generation [139].
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Matrix stiffness also modulates cell-cell assembly, migration, and proliferation.
Cells on compliant substrates (< 1kPa) prefer cell-cell interactions rather than migration
and self –assemble into network. When placed on stiffer substrates, cells prefer cellsubstrate interactions [139,140]. Cellular responses to gradients of different stimuli are
referred as durotaxis, the process by which cells respond to changes in matrix rigidity.
Fibroblasts migrate toward substrates of increasing stiffness [141]. The sensitivity of cell
migration to stiffness gradients may have important implications for disease states such
as fibrosis or tumorigenesis that are accompanied in increases in ECM stiffness.
Stem cell differentiation is also controlled either by matrix stiffness or actomyosin
contractility. Engler and co-workers showed that mesenchymal stem cell differentiation is
controlled by matrix stiffness where neuronal differentiation occurred on soft surface
(two dimensional – monolayer culture condition) substrates and osteogic differentiation
occurred on stiffer 2D substrates [142]. Chondrocytes in stiffer matrices (up to 500 kPa)
tend toward preliferative states rather than differentiated phenotype, resulting in
decreased collgen II synthesis [47,143]. A recent study by Mooney and co-workers
demonstrated that matrix stiffness also governed stem cell commitment in 3D culture.
They encapsulated mesenchymal stem cells in non-biodegradable alginate matrix with
different stiffness under 50:50 mixture of adipogenic and osteogenic medium. At low
elastic modulus, stem cells differentiated toward adipogenic lineage, whereas, at higher
elastic modulus values, stem cells differentiated toward osteogenic lineage even though
cells remains restricted to a spherical morphology during osteogenic differentation [8].
Polymer concentration, the stoichiometry of reactive groups, and crosslinking density are
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all commonly used to tune the mechanical properties of cell-compatible hydrogels and
accordingly to control the cellular microenvironment [60,144,145].
1.5.7 Engineering ECM cues - incorporated biofunctionality
In addition to cell adhesion motif and MMP sensitive peptide sequences (for
degradation), hybrid hydrogel scaffold may require growth factors and morphogens
incorporated to the scaffold backbone for sequestering and controlled release in order to
mimic the native ECM [146,147]. Cell signaling molecule have been covalently attached
to hydrogel polymers to enhance either ECM production (TGFβ tethered to PEG
network) [148] or ectopic bone formation process (oligopeptide derived from BMP-2)
[149]. Multiple factors may also be incorporated into hydrogels to manipulate tissue
formation [150].
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1.6 State of the Art Approaches
There are several state of the art researches ongoing to enhance bioactivities of
3D hybrid hydrogel scaffolds and to better understand cellular activities in 3D culture
conditions.
Additional feedback mechanism, other than stiffness of the matrix, is required for
matrix remodeling. Kubow and coworkers compared native ECM scaffolds with
fibronectin based scaffolds stiffened by chemical crosslinking and showed differential
scaffold remodeling by fibroblasts. Native scaffolds from decellularized ECM were
progressively remodeled over stiffer, manually deposited (crosslinked) fibronectin fiber
(on silicon sheet) based scaffold [151]. Legant and co-workers also pointed out the
importance of spatio-temporal interplay between collagen and FN on matrix remodeling
[152]. The hydrogel networks often lack the fibrillar network structure of the ECM
protein backbone. To address this issue, the scaffolds need to couple self-assembly
mechanism within the network [11,153,154].
In addition to engineering cellular biochemical cues in hydrogel matrix, directed
migration is required for maintenance and development of numerous physiological
processes [19,155]. Cell migration is proportional to adhesion ligand density up to a
critical value [156].
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1.7 Concluding Remarks
Scaffold design is the most important factor for successful in vivo cell
transplantation and in vitro 3D cell culture. The design depends on the target tissue and
microenvironments where transplanted cells reside. The design requirements for
successful cell delivery are biocompatibility, mass transport, mechanical properties
(stiffness), and degradability. These design criteria need to be considered for the
continued enhancement of these scaffolds for regenerative medicine applications. For the
development of a functional tissue construct, it is important to understand the natural
microenvironment of the source cell and the innate mechanisms of cell differentiation and
tissue regeneration. This knowledge forms the backbone of the biomimetic approach for
cell differentiation and tissue regeneration. Significant progress has been made using
PEG hydrogel scaffolds as ECM mimics to support and direct cell behavior and tissue
regeneration. Numerous efforts have focused on investigating the effects of biological
signal identity, gel degradation rate, and mechanical properties on cell behavior, but little
work has been done to independently tune these properties in order to isolate and quantify
the individual effects of these factors on cell behavior. Finally, this dissertation study is
aimed to develop a novel cell transplant scaffold for tissue engineering application with
these design criteria.
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CHAPTER TWO
RESEARCH OBJECTIVES

2.1 Project Rationale
In general, tissue engineering uses the combination of living cells, biocompatible
materials (scaffolds), and suitable biochemical and physical factors to restore, improve or
replace biological functions of a failing tissue or organ [157,158]. Tissue engineering
scaffolds should provide biophysical and biochemical milieus that direct cellular behavior
and function. As a scaffolding material, hydrogels have been widely investigated because
of their biochemical similarity with highly hydrated GAG components of the
extracellular matrix (ECM) and in situ polymerization capability under mild
physiological conditions with highly defined spatio-temporal control. Hydrogels can be
used as carriers for transplanted cells, biochemical factors, or both simultaneously and
matrices that induce morphogenesis ex vivo and in vivo. Hydrogels are made either from
naturally-derived or synthetic polymers, or combinations thereof, referred to as hybrid
hydrogels. This hybrid concept takes advantage of inherent bioactivities of naturally
derived materials and the well-defined, reproducible, and tunable nature of synthetic
polymer networks [6]. During the course of tissue regeneration, the degradation rates of
scaffolds must be matched with the rate of regeneration of newly formed tissues
[159,160]. The native ECM is degraded by various protease activities, mainly by plasmin
and matrix metalloproteinases (MMP) family. The incorporation of protease sensitive
peptides identified from native ECM within the synthetic hydrogel networks renders
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hybrid hydrogels biodegradable and has been used to create 3D matrices for the culture of
a variety of cell types. However, these peptide sequences only possess primary structure,
resulting in reduced degradation rate and require high cost for production for clinical use
[28,110,161]. In addition, these hybrid hydrogel networks often have limited mechanical
properties (less than 1 kPa elastic modulus value) to support cell migration within the
networks. Along with native ECM-inspired peptides or other naturally derived materials
for bioactivity, polyethylene glycol (PEG) has been extensively used as synthetic
backbone of hybrid hydrogels due to its excellent biocompatibility and easy control of
scaffold architecture [45,85]. PEG has been also used as surface coating material for
implants due to its resistance to protein adsorption [162]. So matrix deposition and
assembly on PEG based hydrogel scaffold may be limited [163–165].
Our novel hybrid hydrogel system developed in this dissertation research
represents an opportunity to overcome the limitations of peptide-based hybrid hydrogel
scaffolds. In tissue engineering applications, this system may serve as a cost effective 3D
in vivo cell transplant vehicle that will eventually bring about regeneration of native
tissue ECM composition as well as a substrate for host cell infiltration and colonization.
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2.2 Overall Objective
The overall objective of this project was to develop polyethylene glycol diacrylate
(PEGdA) / hyaluronic acid (HA) semi-interpenetrating polymer networks (semi-IPNs)
capable of supporting 3D cell spreading, migration, differentiation, and extracellular
matrix (ECM) deposition for cell therapy applications. In Specific Aim 1 (Chapter 3), the
mechanism that allows semi-IPNs to support encapsulated cell spreading was identified.
Then semi-IPNs were further optimized by investigating the effect of network
compositions on spreading and migration of encapsulated cells and a selected semi-IPN
composition was tested for long term cellular remodeling. In Specific Aim 2 (Chapter 4),
human mesenchymal stem cells were encapsulated within the optimized semi-IPNs and
cultured under osteogenic conditions to test the ability of semi-IPNs to support long-term
stem cell differentiation. In Specific Aim 3 (Chapter 5), hydrophobic poly-L-lactic acid
(PLLA) nanospheres were incorporated in semi-IPNs to enhance ECM deposition inside
the network.

Figure 2.1 Outline of research objectives.
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2.3 Specific Aims
2.3.1 Specific aim 1
To investigate the mechanism of semi-IPNs to create a space for cell activities
and the effect of network composition on spreading and migration of encapsulated
cells in hydrogel network in order to select the optimal combination for long term
cellular remodeling inside hydrogel scaffold. We hypothesized that the incorporation
of native HA supports initial and long-term survival, spreading, and migration of
encapsulated cells by Hase activity combined with hydrolysis of PEGdA backbone.
Hence we aimed to 1) investigate the changes in physicochemical properties during
photopolymerization of semi-IPN hydrogels consisting of PEGdA and unmodified HA,
2) evaluate the effects of network composition (HA concentration, HA molecular weight,
PEGdA concentration, PEGdA chemistry) on encapsulated human fibroblast spreading,
and 3) prepare semi-IPNs with various PEGdA blends to obtain improved control over
degradation kinetics, and 4) test the ability of the optimal formulation to support long
term cell survival and sustained migration.
2.3.2 Specific aim 2
To test the ability of the optimized semi-IPN to support long term stem cell
differentiation for hard tissue application. We hypothesized that the semi-IPN with
optimal mechanical properties for osteogenic differentiation can support prolonged
osteogenic differentiation of mesenchymal stem cells. Hence we aimed to 1) evaluate
optimized semi-IPNs as 3D microenviroments for osteogenic differentiation of
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encapsulated human mesenchymal stem cells during long-term culture by expression of
osteogenic markers, collagen deposition, and mineralization.
2.3.3 Specific aim 3
To incorporate nano/microspheres in semi-IPNs as hydrophobic domains to
increase ECM deposition. We hypothesized that PEG-based hydrogels support limited
ECM molecule deposition due to its hydrophilic nature and that hydrophobic surfaces of
polylactic acid (PLA) nano/microspheres incorporated in semi-IPN can support ECM
binding and serve as nucleation sites for ECM deposition and assembly. Hence we aimed
to 1) develop preparation and recovery methods for PLA nano/microspheres of varying
size, 2) incorporate nano/microspheres into hybrid semi-IPNs and evaluate cellular
remodeling using human dermal fibroblasts by assessing ECM molecule (collagen)
accumulation both quantitatively and qualitatively by comparison to negative control
group (semi-IPN without nano/microspheres).
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CHAPTER THREE
PEG DIACRYLATE/HYALURONIC ACID SEMIINTERPENETRATING NETWORK COMPOSITIONS FOR
3D CELL SPREADING AND MIGRATION
3.1 Introduction
Hydrogels have been widely investigated as matrices for therapeutic cell
transplantation based upon their ability to be delivered using minimally invasive
methods, crosslinked in situ under mild conditions, and provide viscoelastic mechanical
properties similar to many soft tissues [166,167]. Conventionally, hydrogels for tissue
engineering applications have been prepared from either naturally-derived or synthetic
macromolecules. Many naturally-derived materials such as collagen, fibrin, and
hyaluronic acid (HA) form hydrogels that intrinsically support cell adhesion and cellmediated enzymatic degradation. However, these networks possess relatively limited
mechanical properties and can be vulnerable to rapid degradation and contraction unless
stabilized with additional crosslinking agents. Hydrogels formed from synthetic materials
such as polyethylene glycol (PEG) offer superior control over the network physical and
chemical properties, but lack intrinsic bioactivity to support cell adhesion and cellmediated degradation. Many recent efforts in the field have sought to create hybrid or
biosynthetic hydrogels composed of both naturally-derived and synthetic materials that
combine the strengths and minimize the limitations of each type of material when used
alone [11,58,168].
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One of the most prominent strategies for the creation of hybrid hydrogels has
been the modification of synthetic networks with oligopeptides derived from natural
extracellular matrix (ECM) molecules, including the RGD sequence to support cell
adhesion and matrix metalloproteinase (MMP)-substrate sequences to support proteolytic
degradation [74,169]. Recent work in this field has shown that hybrid networks
containing RGD and MMP-sensitive peptides are effective 3D matrices for the culture of
a variety of cell types and support cell proliferation, migration, and ECM deposition
[89,112,170]. When combined with growth factors, various types of PEG-peptide
hydrogels have been shown to support bone regeneration and angiogenesis in vivo
[89,108,171–174]. Despite their success, there are several limitations to peptide-based
hybrid hydrogels. First, oligopeptides are difficult to synthesize in large quantities and
expensive while most tissue defects requiring cell-based therapy are relatively large
[175]. In addition, most oligopeptides are linear sequences of amino acids only
possessing primary structure, resulting in reduced degradation kinetics relative to the
native macromolecules from which they are derived [161]. Consequently, gel
formulations that support cellular activity are frequently prepared at low polymer
concentrations and crosslinking densities, severely limiting their mechanical properties
[89,176–178]. This has led several groups to explore screening alternative peptide
sequences and strategies for increasing the number of degradable sites [28,110,112,179].
Alternatively, the use of intact or modified naturally-derived macromolecules to
form hybrid hydrogels offers several benefits including substantially lower cost and
preservation of native structure potentially supporting higher rates of enzymatic
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degradation and greater diversity of bioactivity [180]. For example, PEGylated fibrinogen
derivatives have been used to prepare hybrid hydrogels with improved control over
mechanical properties and degradation rate compared to native fibrin that have been used
for orthopaedic, neural, and cardiovascular applications [181–185]. Hybrid hydrogels
based on chemically-modified HA crosslinked with reactive PEG derivatives have been
investigated as degradable adhesion barriers and vocal fold augmentation materials
[163,164,186]. While the above studies have used co-polymer networks, our group has
recently investigated the possibilities of semi-interpenetrating polymer networks (semiIPNs) composed of hydrolytically degradable PEG-diacrylates (PEGdA) and native HA
[187–189]. The previous studies have shown that these hydrogels support increased cell
spreading and proliferation relative to fully synthetic networks that is dependent on
cellular hyaluronidase activity. The objective of the present study was to systematically
examine the effects of PEGdA/HA semi-IPN network composition on cell spreading. 3D
spreading of encapsulated fibroblasts exhibited a biphasic response to HA concentration,
required a minimum HA molecular weight, decreased with increasing PEGdA
concentration, and was independent of hydrolytic degradation at early time points.
Incorporation of native HA increased gel turbidity, suggesting a potential mechanism of
microphase separation resulting in HA-enriched defects in the network structure. Finally,
semi-IPNs with optimized PEGdA degradation rate and HA formulation supported
sustained 3D cell migration in a gel-within-gel encapsulation model.
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3.2 Materials and Methods
3.2.1 Synthesis of PEGdA macromers with ester linkages containing variable alkyl
spacers
Three different types of PEGdA macromers with varying susceptibility to
hydrolytic degradation were synthesized by a two-step process as previously reported
[188]. Briefly, PEG (4000 MW, Fluka, Buchs, Switzerland) was reacted with either
chloroacetyl chloride, 2-chloropropionyl chloride, or 4-chlorobutuyrl chloride (SigmaAldrich, St. Louis, MO) in the presence of triethylamine (TEA, Sigma) at a 1:4:1.8 molar
ratio in dry dichloromethane (Sigma). After 24 hours reaction at room temperature, the
reactants were filtered, washed with sodium bicarbonate and water, dried with anhydrous
sodium sulfate, and then precipitated in ethyl ether. After recovery, each resulting
intermediate product was reacted with sodium acrylate (5X molar ratio) in dry
dimethylformamide (Acros, Morris Plains, NJ) for 30 hours at 50, 85, and 100 ⁰C to yield
PEG-bis-(acryloyloxy acetate) [PEG-bis-AA], PEG-bis-(acryloyloxy propanoate) [PEGbis-AP], and PEG-bis-(acryloyloxy butyrate) [PEG-bis-AB], respectively. The products
were purified by filtration, rotary evaporation, and precipitation in ethyl ether and dried
under vacuum. The structures of each PEGdA and the degree of acrylation were
determined from the 1H-NMR (Brucker 300 MHz, CDCl3) spectra. All samples achieved
acrylation efficiencies greater than 90%.
3.2.2 Synthesis of methacrylated HA (GMHA)
GMHA was synthesized as previously described [189]. Briefly, HA (1g, MW:1.5
MDa, LifeCore Biomedical, Chaska, MN) was dissolved at 1% (w/v) concentration in
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deionized water and then TEA (7.33 mL), glycidyl methacrylate (7.33 ml, Acros), and
tetrabutyl ammonium bromide (7.33 g, Acros) were added with 3 hours mixing between
addition of each reagent. The reaction was allowed to proceed for 12 hours at room
temperature followed by 1 hour at 60 ⁰C. The GMHA product was precipitated in
acetone, re-dissolved in deionized water, dialyzed, and recovered by lyophilization.
3.2.3 Cell culture
Adult normal human dermal fibroblasts (NHDF, Lonza, Walkersville, MD) were
cultured in 75 cm2 tissue culture flasks with DMEM/F-12 50:50 1X media (Mediateach,
Herdon, VA) with L-glutamine supplemented with 10% (v/v) bovine growth serum
(Hyclone, Logan UT), and 50 U/mL penicillin and 50 µg/mL streptomycin (Mediatech).
Medium was changed every 2 days and cells were passaged at a 1:3 ratio for expansion.
All encapsulation studies were done with cells between passages 4 and 5.
3.2.4 Effect of semi-IPN network composition on fibroblast morphology
HA and GMHA (1.75% w/v) and PEGdA (30% w/v) stock solutions were
prepared in 1X-PBS (0.1 M, pH 7.4).

Acryl-PEG-GRGDS was synthesized by

conjugating GRGDS peptide (Bachem, Torrance, CA) to acryl-PEG-NHS (Jenkem,
Beijing, China) as previously described [169]. Based upon pilot studies, 6% w/v PEGbis-AP containing 0.36% w/v 1.5 MDa HA was selected as an initial baseline gel
composition. In order to systematically investigate the effect of semi-IPN network
composition on the morphology of encapsulated fibroblasts, a series of studies was
performed in which one parameter of the gel composition (HA concentration, HA
molecular weight, PEGdA concentration, PEGdA chemistry) was varied while the others
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were held constant. 250 µl gel precursor solutions were prepared containing PEGdA and
HA at varying concentrations, acryl-PEG-GRGDS (1 µmol/mL), 2-hydroxy-1-[4(hydroxyethoxy) phenyl]-2-methyl-1-propanone (I-2959, BASF, Florham Park, NJ, 0.1%
w/v), and NHDF (5×106 cells/mL). Sample volumes (50 µl) were pipetted in between
glass coverslips separated by 1 mm Teflon spacers and exposed to low intensity UV light
(365nm, 10mW/cm2, Blak-Ray B100-AP, Upland, CA) for 5 minutes on each side of the
disc as previously described [Kutty JK J Biomater Sci Polym Ed 2009]. Hydrogels with
encapsulated cells were cultured in Petri dishes (BD, San Jose, CA) with 3mL culture
medium. For studies examining the effect of HA concentration, homogeneous synthetic
PEGdA hydrogels (no HA) and co-polymer networks in which native HA was replaced
with the same concentrations of GMHA were also prepared. For the study examining the
effect of PEGdA concentration, the HA concentration was also varied in order to
maintain the 6% w/w ratio of HA:PEGdA present in the baseline gel composition with
6% w/v PEGdA and 0.36% w/v HA. Gels containing encapsulated cells (n=4 samples /
group) were cultured for 7 days, fixed with 4% paraformaldehyde (Sigma-Aldrich) in
1X-PBS for 1 hour, permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) in 1X-PBS
for 5 minutes and, stained with Alexa Fluor 647-phalloidin (Life Technologies, Grand
Island, NY). Samples were imaged using Nikon Ti-Eclipse confocal microscope. Cell
morphology at 200µm depth inside hydrogel was visualized and compared to assess cell
spreading and network connectivity. Average cell circularity (dimensionless parameter
defined as circularity = (4π×area)/perimeter2, ranging from 0 to 1, with 1 being a perfect
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circle) was calculated from confocal images using the NIH Image J Software Analyze
Particles feature.
3.2.5 Hydrogel turbidity and mechanical properties
To assess gel turbidity, PEG-bis-AP semi-IPNs (6% w/v, 100 µL volume) with
varying HA concentration/molecular weight and copolymerized hydrogels with GMHA
without NHDF cells (n=4 per group) were photopolymerized as described above. As an
additional control, semi-IPNs were also prepared with 0.36% w/v dextran (80 and 1100
kDa, Sigma). The sample discs were placed in 24 well plates and absorbance was
measured at 570 nm using µQuant UV-VIS spectrophotometry (BIO-TEK Instruments).
The final absorbance values were normalized by subtracting the average value of blank
wells. Turbidity was calculated as Turbidity = -ln(10-A), where A=absorbance.
To measure hydrogel mechanical properties, semi-IPNs composed of 1) PEG-bisAP (6% w/v) with varying concentrations of HA and 2) varying concentrations of PEGbis-AP with HA maintained at 6% w/w HA:PEGdA were photopolymerized as described
above. Hydrogels were cut into custom made dumbbell shaped samples with 30 mm
gauge length, 5 mm width, and 1 mm thickness. The samples (n=3/group) were subjected
to 35% strain at 5 mm/min using an MTS Synergy 100 (MTS Systems Corporation) at
room temperature. Each sample was tested three times to ensure that slippage did not
occur.
3.2.6 Hydrogel degradation study
To evaluate the effect of PEGdA macromer chemistry on hydrogel degradation,
semi-IPNs were crosslinked as 1) homogeneous networks containing each of the 3
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different PEGdAs and 2) blended networks composed of all 3 PEGdAs mixed in varying
ratios. All samples were prepared at 6% w/v total PEGdA concentration with 0.36% HA
w/v (1.5 MDa). After photopolymerization, samples were equilibrated with NHDF
culture medium with 0.1% w/v sodium azide (Sigma-Aldrich), washed with deionized
water, lyophilized, and weighed (Wd0). Samples were incubated in 4mL of cell culture
media with sodium azide in scintillation vials in a cell culture incubator with 5% CO2
supply at 37 ⁰C. Medium was changed once every 2 days. At each time point, samples
(n=3/group) were collected, washed with deionized water, lyophilized, and weighed
(Wdt). Percent mass loss was calculated as [(Wd0–Wdt)/Wd0]×100.
3.2.7 NHDF morphology and migration in PEGdA blend / HA semi-IPNs
PEGdA macromer blend (12.5% PEG-bis-AA; 37.5% PEG-bis-AP; 50.0% PEGbis-AB) at 6% w/v final concentration was prepared with 0.36% w/v HA (MW: 1.5 MDa)
and acrylate-PEG-GRGDS (1 µmol/mL) and I-2959 (0.1%). In order to evaluate
fibroblast morphology during long-term culture, NHDF (10×106 cells/mL final
concentration) were uniformly dispersed within the gel precursor solution and
photopolymerized as described above. Hydrogel samples (n=4/time point) were cultured
in 35 mm Petri dishes for 3, 7, 14, 21, 28, and 35 days, then fixed and stained with Alexa
647-phalloidin and imaged by confocal microscopy. To assess the gel’s capacity to
support cellular invasion and migration, a gel-within-gel encapsulation system was used.
NHDF were first entrapped within small fibrin clots (120,000 cells / 4 µl) prepared from
1% human fibrinogen (Enzyme Research Laboratories) with 2.5 mM calcium chloride
(Sigma) and 0.001 U/mL thrombin (Enzyme Research Laboratories). After gelation for
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15 minutes at 37⁰C, NHDF-loaded fibrin clots were gently placed within 50 µl solutions
of the semi-IPN formulation described above (without additional cells) and gels formed
by photopolymerization. As controls, NHDF-loaded fibrin clots were also polymerized
within hydrogels of the same composition without native HA and co-polymerized
networks with comparable concentrations of GMHA. Hydrogel samples were imaged at
day 0, 3, 7, 10, 14, 18, and 21 using phase contrast microscopy (Zeiss). For 3D images,
NHDF-loaded fibrin clots were harvested at day 14 and prepared for confocal microscopy
as described above. Samples were three dimensionally scanned with 20 µm z-interval.
3.2.8 Statistical analysis
Quantitative data for hydrogel turbidity and elastic modulus were compared by
ANOVA using Tukey’s method for post-hoc comparisons (one-way ANOVA followed
by Bonferroni’s multiple comparison test). p values < 0.05 were considered to be
statistically significant. All quantitative data are presented as mean ± standard deviation.

3.3 Results
3.3.1 Effect of HA concentration on 3-D fibroblast morphology
NHDF were encapsulated in photopolymerized PEG-bis-AP hydrogels, PEG-bisAP / HA semi-IPNs containing varying concentrations of HA, and PEG-bis-AP / GMHA
copolymer hydrogels. After 7 days in culture, cells in PEG-bis-AP hydrogels without HA
were unable to spread and retained a spherical morphology (Figure 3.1A, circularity
=0.65±0.08). In contrast, PEG-bis-AP/HA semi-IPNs supported extensive cell spreading
that qualitatively appeared to be greatest at 0.36 and 0.54% HA and moderately decrease
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at 0.72% HA and higher (Figure 3.1B-E), although all samples had circularity values
ranging between 0.11-0.14 with no significant differences among these groups. Cells
within copolymer hydrogels formed with comparable amounts of GMHA were unable to
spread (Figure 1F, circularity=0.68±0.09), demonstrating that the ability of PEG-bisAP/HA semi-IPNs to support cell spreading is a unique property of the semi-IPN network
structure.

Figure 3.1 Confocal microscopy images of actin-stained human dermal fibroblasts
encapsulated within 6% w/v PEG-bis-AP hydrogel (A), PEG-bis-AP/HA semi-IPNs
containing 0.18% w/v HA (B), 0.36% w/v HA (C), 0.54% w/v HA (D), 0.72% w/v HA
(E), and PEG-bis-AP/GMHA co-polymer hydrogel containing 0.36% w/v GMHA (F) at
200 µm depth after 7 days culture, scale bar = 100 µm.
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3.3.2 Physico-chemical characterization of PEG—bis-AP/HA semi-IPNs and hydrogels
The effect of HA incorporation on hydrogel physico-chemical properties was
analyzed by measuring turbidity and tensile properties. Figure 3.2 shows the turbidity of
both PEG-bis-AP/HA semi-IPNs and PEG-bis-AP/GMHA copolymer hydrogels
measured by spectrophotometry. Relative to PEG-bis-AP hydrogels, incorporation of
native HA to form semi-IPNs significantly increased sample turbidity in a dosedependent manner. The turbidity of copolymer hydrogels containing comparable amounts
of GMHA was not significantly different than the PEG-bis-AP control at any
concentration tested.
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Figure 3.2 Turbidity of 6% w/v PEG-bis-AP hydrogels, PEG-bis-AP/HA semi-IPNs
containing varying amounts of HA, and PEG-bis-AP/GMHA copolymer hydrogels
containing varying amounts of GMHA. *=p<0.05 relative to PEG-bis-AP hydrogel and
#=p<0.05 between groups.
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The mechanical properties of PEG-bis-AP/HA semi-IPNs were measured by
tensile testing. The elastic modulus of semi-IPNs containing 0.18% w/v HA was
modestly higher than the PEG-bis-AP hydrogel without HA and then elastic moduli
values decreased with increasing HA content with the differences being statically
significant at the two highest concentrations (Figure 3.3).

Figure 3.3 Elastic modulus of 6% w/v PEG-bis-AP hydrogels and PEG-bis-AP/HA semiIPNs containing varying amounts of HA. *=p<0.05 relative to PEG-bis-AP hydrogel and
#=p<0.05 between groups.
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3.3.3 Effect of HA molecular weight on 3-D fibroblast morphology and gel turbidity
NHDF were encapsulated in semi-IPNs containing 6% w/v PEG-bis-AP and
0.36% w/v HA of varying molecular weight (MW). Semi-IPNs containing low MW (100
kDa) HA did not support the spreading of fibroblasts, which retained a spherical
morphology (circularity = 0.69±0.03) after 7 days in culture (Figure 3.4). At 700 kDa HA
MW and higher, all samples exhibited comparable cell spreading and circularity values
ranging between 0.17-0.21. These results demonstrate that a minimum threshold for HA
MW exists that is required to support cell spreading. Semi-IPNs prepared with high MW
HA (700-1500 kDa) that supported cell spreading exhibited significant increases in gel
turbidity, while the 100 kDa HA group was not significantly different from the PEGdA
only control (Figure 3.5). Semi-IPNs prepared with dextran at both low (80 kDa) and
high (1100 kDa) MW did not exhibit significant changes in turbidity relative to the
PEGdA control.
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Figure 3.4 Confocal microscopy images of actin-stained human dermal fibroblasts
encapsulated within 6% w/v PEG-bis-AP / 0.36% w/v HA semi-IPNs prepared using HA
with molecular weights of 100 kDa (A), 700 kDa (B), 1.0 MDa (C) and 1.5 MDa (D) at
200 µm depth after 7 days culture, scale bar = 100 µm.
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Figure 3.5 Turbidity of 6% w/v PEG-bis-AP hydrogel and PEG-bis-AP/HA and PEGbis-AP/dextran semi-IPNs containing 0.36% w/v HA or dextran of varying molecular
weight. *=p<0.05 relative to PEG-bis-AP hydrogel and #=p<0.05 between groups.
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3.3.4 Effect of PEG diacrylate macromer concentration and chemical structure on 3-D
fibroblast morphology
NHDF were encapsulated in semi-IPNs containing various concentrations of
PEG-bis-AP and HA, maintaining constant 6% w/w PEG/HA ratio. Semi-IPNs
containing 4-6% PEG-bis-AP effectively supported cell spreading at 7 days with the most
robust response observed at the 4% concentration (Figure 3.6). Cell spreading was
substantially reduced as the PEG-bis-AP concentration was increased to 8% and
minimally present at 10%. Circularity values steadily increased with increasing PEGdA
concentration, although the maximum value reached was 0.32±0.02 at 10% PEGdA,
which was significantly lower that PEGdA hydrogel controls without HA. Tensile testing
showed that semi-IPN elastic modulus increased from 10.2 +/- 2.07 kPa at 6% to 28.0
w/v +/-2.65 kPa and 76.0 +/- 3.61 kPa at 8 and 10% concentration, respectively. Samples
prepared at 4% were visibly weaker and could not be evaluated by tensile testing.
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Figure 3.6 Confocal microscopy images of actin-stained human dermal fibroblasts
encapsulated within PEG-bis-AP / HA semi-IPNs containing varying concentrations of
PEG-bis-AP and HA; 4% w/v PEG-bis-AP with 0.24% w/v HA (A), 5% w/v PEG-bisAP with 0.30% w/v HA (B), 6% w/v PEG-bis-AP with 0.36% w/v HA (C), 8% w/v PEGbis-AP with 0.48% w/v HA (D) and 10% w/v PEG-bis-AP with 0.60% w/v HA (E) at
200 µm depth after 7 days culture, scale bar = 100 µm.
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NHDF were also encapsulated in semi-IPNs prepared from various PEGdA
macromers with varying chemical structures (PEG-bis-AA, PEG-bis-AP, or PEG-bisAB) previously shown to provide different susceptibility to hydrolytic degradation [188].
As early as 3 days post-encapsulation, fibroblast spreading was observed in all semi-IPN
compositions (Figure 3.7). Circularity values for all three groups ranged from 0.17-0.21
without significant differences. Cells encapsulated within homopolymer hydrogels of
even the most rapidly hydrolytically degrading macromer (PEG-bis-AA) without HA did
not exhibit any spreading (data not shown). These results confirm that the initiation of
cell spreading within these gels is attributable to the HA component and independent of
PEG macromer chemistry and hydrolytic degradation.

Figure 3.7 Confocal microscopy images of actin-stained human dermal fibroblasts
encapsulated within 6% w/v PEGdA / 0.36% w/v HA semi-IPNs formed from PEG-bisAA (A), PEG-bis-AP (B), and PEG-bis-AB (C) macromers at 200 µm depth after 3 days
culture, scale bar = 100 µm.
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3.3.5 Degradation kinetics of various semi-IPNs
In preparation for longer-term studies, the hydrolytic degradation kinetics of
semi-IPNs prepared from PEGdA macromers with varying chemical structure were
studied during incubation in serum-containing medium. For semi-IPNs prepared from
each of the three different PEGdA macromers individually, PEG-bis-AA semi-IPNs
showed the fastest degradation rate (complete degradation at day 7), PEG-bis-AP showed
intermediate degradation rate (complete degradation at day 18), and PEG-bis-AB based
semi-IPNs showed the slowest degradation rate (ca. 34% mass loss at day 42) (Figure
3.8A). In order to achieve a broader range of degradation profiles, blended PEGdA
compositions (C1-C7, Figure 3.8B) containing the 3 different PEGdA macromers in
various ratios were evaluated. A gel composition consisting of 12.5 % PEG-bis-AA,
37.5% PEG-bis-AP, and 50% PEG-bis-AB (‘C1’) was found to exhibit relatively linear
mass loss over 5 weeks and was used for all further studies.
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Figure 3.8 Mass loss of 6% w/v PEGdA / 0.36 % w/v semi-IPNs prepared with
homogeneous (A) and blended (B) PEGdA composition in routine culture medium
containing 0.1% w/v sodium azide.
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3.3.6 Long-term 3-D fibroblast culture in blended PEGdA/HA semi-IPNs
In the first long-term culture study, NHDF were homogeneously encapsulated
within semi-IPNs (6% w/v ‘C1’ PEGdA blend / 0.36% w/v HA) and cultured for 35 days.
As shown in Figure 3.9, NHDF spreading progressively increased over the culture period
and the cell number exhibited little change, suggesting limited cell proliferation. This is
in contrast to blended PEGdA only (no HA) or blended PEGdA/GMHA hydrogel
controls, where cells remained restricted to a spherical morphology and cell number
visibly decreased by approximately 50% within 14 days (data not shown).

Figure 3.9 Confocal microscopy images of actin-stained human dermal fibroblasts
encapsulated within 6% w/v blended PEGdA (C1-12.5% PEG-bis-AA, 37.5% PEG-bisAP, 50.0% PEG-bis-AB) / 0.36% HA semi-IPNs at 200 µm depth after 7 days (A), 21
days (B), and 35 days (C) culture, scale bar = 100 µm.
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In order to assess the ability of NHDF to migrate through blended PEGdA/HA
semi-IPNs, NHDF were pre-encapsulated within fibrin clots that were subsequently
entrapped within semi-IPNs during photopolymerization. Within 3 days, NHDF began to
migrate out of the fibrin clots into the surrounding semi-IPNs (Figure 3.10A). NHDF
migration progressively increased over time, reaching 1.5 mm depth within 21 days
(Figure

3.10B/C).

NHDF-loaded

fibrin

clots

encapsulated

within

blended

PEGdA/GMHA copolymer hydrogels as a control exhibited limited migration into the
surrounding gel after 21 days in culture (Figure 3.10D). 3D confocal reconstruction
confirmed that NHDF-loaded clots and cellular outgrowth was occurring within the 3D
network volume rather than on the gel surface (Figure 3.9E).
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Figure 3.10 Migration of human dermal fibroblasts pre-encapsulated within 1% w/v
fibrin clots into surrounding 6% w/v blended PEGdA (C1-12.5% PEG-bis-AA, 37.5%
PEG-bis-AP, 50.0% PEG-bis-AB) / 0.36% w/v HA semi-IPNs after 3 days (A), 7 days
(B), 14 days (C) 21 days (D) and 6% w/v blended PEGdA (C1) / 0.36% w/v GMHA
copolymer hydrogels after 21 days (E) culture. 3D confocal reconstruction of fibroblasts
migrating from fibrin clots into surrounding 6% w/v blended PEGdA (C1) / 0.36% w/v
HA semi-IPN after 14 days in culture (F). Scale bars = 500 µm.
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3.4 Discussion
The efficacy of cell-based therapy can be substantially improved by the use of
scaffolds that serve as a provisional matrix for cell adhesion, migration, and proliferation.
Synthetic hydrogels offer injectable matrices with defined structure and composition;
however, such networks generally possess nanometer-scale mesh sizes that restrict
encapsulated cells to a spherical morphology. For most anchorage-dependent cell types,
the ability to adopt a spread morphology is essential for survival, migration, proliferation,
and differentiation [190–192]. Therefore, there is a critical need for the development of
hybrid networks incorporating naturally-derived components that support localized, cellmediated remodeling.
As an alternative to the prevailing approach of crosslinking synthetic
macromolecules with protease-sensitive oligopeptides, our group has previously shown
that semi-IPNs composed of hydrolytically degradable PEG diacrylates and native HA
support rapid 3D cell spreading in a hyaluronidase-dependent manner [187]. These
materials are attractive candidates because other PEG and HA derivatives have been
successfully translated for clinical applications [193,194]. In this study, the effect of
semi-IPN network composition on 3D cell spreading was systematically examined,
beginning with a baseline gel formulation composed of 6% w/v PEG-bis-AP macromer
that provides an intermediate rate of hydrolytic degradation and 0.36% w/v HA (1.5
MDa). Fibroblast spreading in 3D exhibited a biphasic response to varying the
concentration of HA, initially increasing at levels higher that those originally tested by
Kutty et al. (0.18% w/v), then subsequently declining at 0.72% or higher. We
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hypothesized that the activity of PEGdA/HA semi-IPNs originates from polymerizationinduced phase separation as previously suggested by Ouasti and co-workers. [195]. In
support of this hypothesis, fibroblast spreading was completely eliminated when native
HA was replaced with a methacrylated HA derivative (GMHA) that could be covalently
incorporated into the network, thereby limiting its potential to undergo phase separation.
Gel turbidity was also evaluated as a quantitative measure of phase separation and found
to increase with increasing HA concentration in semi-IPNs, but not copolymerized
hydrogels containing GMHA. Finally, when the HA molecular weight was varied, it was
observed that cell spreading required relatively high HA molecular weight, consistent
with the increased tendency for phase separation as solute molecular weight increases.
Interestingly, semi-IPNs prepared with dextran, even at high molecular weight, did not
result in increased gel turbidity. This result suggests that HA is unique among various
materials tested for the non-crosslinked component of these semi-IPNs, including
collagen and gelatin in previous studies [187], in its ability to induce phase separation, at
least to a degree sufficient to create microdomains that allow cell spreading. This is likely
attributable to the unique properties of HA in terms of water-binding capacity; H-bonding
and self-association; and solution rheology [196].
The ability of cells to spread and migrate in 3D has also been found to be
dependent on the hydrogel’s mechanical properties [112,176,178]. Tensile testing showed
that the elastic modulus of semi-IPNs decreased with increasing HA concentration, likely
due to the increasing level of phase separation creating defects within the network
structure. However, it is particularly important to note that the elastic moduli values for
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6% PEG-bis-AP with 0.36% and 0.54% HA that most effectively supported cell
spreading ranged between 8-10 kPa. In contrast, most peptide-crosslinked hydrogels that
support cell spreading/migration are characterized by elastic shear moduli values
generally around and below 1 kPa, approximately an order of magnitude lower
[96,175,179,197]. The higher mechanical properties of PEGdA/HA semi-IPNs offer
several advantages including increased mechanical stability and resistance to cellmediated contraction. In addition, recent studies have shown that substrate mechanics
influence stem cell differentiation in both 2D and 3D culture systems and the elastic
modulus of PEGdA/HA semi-IPNs is in close approximation to values shown to most
efficiently promote osteogenic differentiation of human mesenchymal stem cells [8,142].
We also investigated the effect of variation in PEGdA concentration and chemical
composition on 3D fibroblast spreading. Higher polymer concentrations resulted in
increased mechanical properties and strongly inhibited cell spreading at PEGdA
concentrations of 8% w/v and greater, despite corresponding increases in HA
concentration to maintain a constant PEGdA:HA w/w ratio. This observation is consistent
with many previous reports in the literature, although as noted above, the range of
mechanical

properties

was

much

higher

in

PEGdA/HA

semi-IPNs

[112,176,178,181,197]. At 6% w/v, all three PEGdA chemical compositions supported
the initiation of cell spreading within three days. In combination with previous work
showing that the most slowly degrading PEG-bis-AB exhibits negligible mass loss at 3
days [189], this result demonstrates that the initiation of cell spreading in these semi-IPNs
is independent of hydrolytic degradation and based solely upon cell-mediated degradation
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of HA. The ability of cells to begin spreading rapidly is another important advantage of
these PEGdA/HA semi-IPNs relative to peptide-crosslinked networks in which a lag
period of 7-14 days is often observed between the time of encapsulation and the initiation
of cell spreading, particularly when encapsulation is performed with dissociated
individual

cells

[28,96,110,170,198].

Collectively,

these

results

suggest

that

photopolyermization-induced phase separation creates HA-enriched defects within the
network structure that facilitate rapid hyaluronidase-mediated localized degradation that
supports cell spreading.
One challenge to the application of these semi-IPNs for long-term culture and
translational applications was that none of the PEGdA macromers when used alone
provided an ideal degradation profile. PEG-bis-AA and PEG-bis-AP degraded too rapidly
resulting in loss of mechanical integrity and contraction, while PEG-bis-AB degraded too
slowly, with little further cell spreading observed beyond that at 3-7 days and subsequent
reduction in cellularity at later time points, presumably as a result of cell death.
Previously, Quick and co-workers showed that blending acrylated PLA-b-PEG-b-PLA
macromers with different PLA block lengths and therefore hydrolytic degradation rate
could produce gels with more finely controlled and linear rates of degradation [199]. We
adapted this approach by creating blends of the three different PEGdAs used in this study
to obtain a formulation displaying relative linear mass loss over 5 weeks. These
degradation studies were performed in serum-containing medium to reflect culture
conditions because gel degradation was originally noticed to be much more rapid than
previously observed during degradation in PBS, likely due to the contribution of serum
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esterase enzymes. Using the selected blend formulation of PEGdA, sustained cell
spreading and viability was observed for up to 35 days. Finally, a gel-within-gel
encapsulation model was used to test the ability of blended PEGdA/HA semi-IPNs to
support cell invasion and sustained migration. Fibroblasts pre-encapsulated within fibrin
clots began sprouting into the surrounding semi-IPN and progressively migrated radially
outward for over 21 days. As in our dispersed cell encapsulation model, copolymer
hydrogels prepared with GMHA were unable to support this behavior. These results
suggest that the HA-enriched zones created by phase separation are sufficiently interconnected, in combination with gradual hydrolytic degradation, to support sustained cell
migration.

3.5 Conclusions
These studies demonstrate that through systematic optimization of network
composition, PEGdA/HA semi-IPNs can be formulated to provide dynamic
microenvironments that support cell survival, spreading, and sustained migration. The
bioactivity of these networks is a unique feature of the semi-IPN structure derived from
polymerization-induced phase separation that creates HA-enriched micro-domains
susceptible to cell-mediated enzymatic degradation in combination with prolonged
hydrolytic degradation. Specific advantages of these semi-IPNs relative to existing hybrid
hydrogels are the ability to support the rapid initiation of cell spreading within three days
post-encapsulation and the provision of improved mechanical properties.
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CHAPTER FOUR
OSTEOGENIC DIFFERENTIATION OF
HUMAN MESENCHYMAL STEM CELLS IN
SEMI-INTERPENETRATING NETWORK

4.1 Introduction
The rationale for bone tissue engineering originated from the limitations of
traditional bone graft techniques. Bone defects resulting from trauma and tumor resection
are common clinical problems. Bone tissue has the ability to regenerate, but when a
defect of critical size needs to be bridged, the repair attempt fails in most cases.
Replacing missing bone with material from the patient’s own bone (autograft) is still
considered as an ideal standard. However, the limited supply from the patient and
possible donor site morbidity are problematic. Allograft is another bone graft technique,
replacing missing bone with material from a donor (bone bank). In this technique, there is
the potential risk of disease transmission and demand still outstrips supply. Healing can
also be inconsistent due to its heterogeneity [200]. As a new practice, bone tissue
engineering is an alternative strategy to regenerate bone using osteogenic progenitor or
mature cells on osteoconductive scaffold material with or without appropriate
osteoinductive growth factors [201–204]. Regarding bone graft substitutes, they should
be osteoconductive which refers to the ability to provide an interconnected structure for
new bone formation on its surface (or within the entire volume of construct) by mature
bone forming cells. The objective of bone graft substitutes is to reliably replicate healthy
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autograft. The research focus is to develop the matrix material with better biological
compatibility and functionality, cell adhesion surface, bioresorbable capability, and drug
delivery potential to release growth factors (stimulating bone repair) [202,205]. The most
successfully commercialized osteoconductive three dimensional scaffold materials are
bioceramics which undergo ex vivo fabrication prior to cell seeding due to harsh
condition of fabrication [206–208]. This material by itself sometimes exhibits poor
osteoconductive capability, shown as limited bone formation only at the boundary of the
defects [209] and may require additional fabrication processes when the defect site
geometry is complicated [208]. Alternatively, hydrogel scaffolds are widely studied as
non-load bearing scaffold materials for bone tissue engineering due their ability to be
delivered in a minimally invasive manner and polymerized in situ in the presence of cells
under mild conditions [44,210,211].
For osteogenic cells, the fundamental studies have focused on mesenchymal
stromal cells obtained from bone marrow because these cells have shown high osteogenic
activity and can be cultivated ex vivo in quantities appropriate for clinical applications.
They also show the advantage of low morbidity and cost over autograft. However, this
has little clinical impact due to the limited number of clinical studies [212]. The ability of
mesenchymal stem cells to differentiate has been found to be dependent on
scaffold/substrate mechanical properties in both monolayer (2D) and three-dimensional
(3D) culture systems [8,142]. Specifically, substrates with elastic moduli ranging from 5
kPa to 40 kPa favor osteogenic differentiation of mesenchymal stem cells in 3D culture
[8,213–215]. As an in situ forming or minimally invasive cell transplant scaffold
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candidate, hybrid hydrogels are designed to integrate the precise control of
composition/properties provided by synthetic networks with the bioactivity of naturallyderived materials. PEG derivatives crosslinked with MMP-sensitive peptides are a
prominent example and have been widely used for in vitro culture models and in vivo
tissue engineering [11,58,168]. However, most peptide-crosslinked hydrogels that
support cell spreading/migration are characterized by elastic shear moduli values
generally around and below 1 kPa, approximately an order of magnitude lower than the
optimal range for osteogenic differentiation [96,175,179,197,216]. Attempts to increase
the elastic modulus of hydrogel scaffolds often requires higher cross-linking density of
the network, resulting in a spherical morphology of encapsulated stem cells, which is not
favorable to cell viability and also for osteogenic differentiation of encapsulated stem
cells [170,217,218]. To achieve high elastic modulus and proper rate of degradation
simultaneously, several groups explored alternative strategies such as increasing the
number of degradable sites [112,179]. However, this approach has a practical limitation
for cell based therapy due to its production cost and requirement of large quantity for
application [175].
In previous research, the incorporation of native hyaluronic acid (HA) into
photocrosslinked networks of hydrolytically degradable PEG diacrylates (PEGdA)
creates semi-interpenetrating networks (semi-IPNs) that support increased cell spreading
and proliferation relative to fully synthetic networks that is dependent on cellular
hyaluronidase activity [187,188]. In Chapter 3, the network composition of semi-IPNs
(6% w/v PEG diacrylate with 0.36% hyaluronic acid at 1.5 MDa molecular weight) was
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identified to best support cell spreading and network formation. Selected semi-IPNs with
PEGdA blends and HA supported prolonged 3D fibroblast culture for 35 days and
sustained 3D cell migration. It is particularly important to note that the elastic moduli
values of semi-IPNs for 6% PEG-bis-AP with 0.36% and 0.54% HA that most effectively
supported cell spreading ranged between 8-10 kPa, which is in close approximation to
values shown to most efficiently promote osteogenic differentiation of hMSCs in 3D
culture condition [8]. In this study, semi-IPN application will be expanded toward stem
cell therapy, especially osteogenic differentiation of mesenchymal stem cells (MSCs) for
possible hard tissue applications. In situ photopolymerization of autologous cell
encapsulated, mechano-mimetic, degradable hydrogels can be used as bone void-filler in
non-load bearing site and act as 3D cell niche [219]. Human mesenchymal stem cells
(hMSCs) have encapsulated within selected semi-IPNs and cultured under osteogenic
differentiation conditions for up to 35 days. Encapsulated hMSCs exhibited alkaline
phosphatase expression, osteogenic gene expression, and the progressive accumulation of
collagen and mineralization. Histology and quantified calcium contents showed calcified
tissue formation at the end of 3D culture. Osteogenic differentiation of encapsulated
hMSCs followed similar mineralization process and relatively early osteoblast maturation
process compared to its gene expression profile in monolayer (2D) culture from other
study [220].
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4.2 Materials and Methods
4.2.1 Synthesis of PEGdA macromers with ester linkages containing variable alkyl
spacers
Three PEGdAs with varying susceptibility to hydrolytic degradation were
synthesized by a two-step process. First, PEG (Fluka, MW 4000) was reacted with
chloroacetyl chloride, 2-chloropropionyl chloride, or 4-chlorobutyryl chloride and then
the resulting intermediate products were reacted with sodium acrylate to obtain PEG-bisAA, PEG-bis-AP, or PEG-bis-AB, as previously described in Chapter 3. All samples
achieved acrylation efficiencies greater than 92.5%, determined from 1H-NMR (Bruker
300 MHz, CDCl3) spectra.
4.2.2 In vitro cell culture
For cell growth and expansion, human mesenchymal stem cells (hMSCs, Lonza,
Walkersville, MD) were cultured in 75cm2 tissue culture flasks at 37⁰C with 5% CO2
supply. Cells were cultured with low glucose DMEM with L-glutamine media (Life
Technologies, Grand Island, NY) supplemented with 10% (v/v) MSC qualified fetal
bovine serum (Life Technologies), 50U/mL penicillin and 50µg/mL streptomycin
(Mediatech) and 10 ng/mL basic FGF (PeproTech, Rocky Hill, NJ).

Medium was

changed every 2 days and cells were passaged at a 1:3 ratio for expansion after reaching
85 to 90% confluence. All encapsulation studies were done with cells between passages 5
and 6.
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4.2.3 hMSC encapsulation in semi-IPNs
Hyaluronic acid with 1.5 MDa molecular weight (Lifecore Biomedical, Chaska,
MN) stock solution (1.75% w/v) and PEGdA (30% w/v) stock solutions were prepared in
1X-PBS (0.1M, pH 7.4). Acryl-PEG-GRGDS was synthesized by conjugating GRGDS
peptide (Bachem, Torrance, CA) to acryl-PEG-NHS (Jenkem, Beijing, China) as
previously described [169]. Gel precursor solutions (250 µL in 1X PBS) were prepared
containing 6% w/v PEGdA blend (12.5% PEG-bis-AA, 37.5% PEG-bis-AP, and 50.0%
PEG-bis-AB) and 0.36% w/v HA, acryl-PEG-GRGDS (1µmol/mL), 2-hydroxy-1-[4(hydroxyethoxy) phenyl]-2-methyl-1-propanone (I-2959, BASF, Florham Park, NJ,
0.05% w/v), and hMSCs (final concentration at 12.5×106 cells/mL). hMSCs were
uniformly dispersed within the gel precursor solution by pipetting. Sample volumes (55
µl) were pipetted in between glass separated by 1 mm Teflon spacers and exposed to low
intensity UV light (365nm, 10mW/cm2, Black-Ray B100-AO, Upland, CA) for 5 minutes
on each side of the disc. Hydrogels with encapsulated cells were cultured in 35 mm
diameter Petri dishes (BD, San Jose, CA) with 3mL culture medium. For osteogenic
differentiation studies, encapsulated hMSCs were cultured with low glucose DMEM
media with L-glutamine (Life Technologies) supplemented with 10% (v/v) MSC
qualified fetal bovine serum (Life Technologies), 50U/mL penicillin and 50µg/mL
streptomycin (Mediatech) in the presence of osteogenic differentiation supplements (50
µM ascorbic acid-2-phosphate (right?), 10 mM β-glycerophosphate, and 100 nM
dexamethasone, all from Sigma-Aldrich).
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4.2.4 Monitoring of encapsulated hMSC morphology under osteogenic differentiation
condition
hMSCs were encapsulated as described above in semi-IPNs. Hydrogel samples
(n=3/time point) were cultured in 35mm Petri dishes for 21 and 28 days, then fixed with
4% paraformaldehyde (Alfa Aesar, Ward Hill, MA), permeabilized with 0.1% Triton X100 (Sigma-Aldrich), and stained with Alexa Fluor 647-phalloidin (Life Technologies).
The morphologies of encapsulated cells were imaged using a Nikon Eclipse Ti confocal
microscopy at 200 µm z-depth.
4.2.5 Alkaline phosphatase (Al-P) activity
hMSCs encapsulated in semi-IPNs were prepared and cultured in full osteogenic
media for 7, 14, 21, and 28 days. At each time point, four hydrogel samples were
harvested (n=4), washed twice with 1X PBS for 3 minutes each, and stored at -80⁰C
freezer. For analysis, hydrogel samples were thawed and lysed with 0.1% Triton X-100
(Sigma) solution by manual homogenization. Residual hydrogel debris and cells were
removed by centrifugation at 10,000 rpm for 5 minutes and supernatant was recovered for
analysis. Prior to alkaline phosphatase activity measurement, total protein concentration
was measured for normalization of alkaline phosphatase activity using BSA Total Protein
Assay kit (Thermo Scientific, Waltham, MA). Alkaline phosphatase activity of
encapsulated hMSCs was measured using alkaline phosphatase activity kit according to
manufacturer’s protocol (Sigma-Aldrich).
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4.2.6 Quantitative RT-PCR
hMSCs encapsulated in semi-IPNs were prepared and cultured in growth
(expansion) media for 1 day (24 hours). After 1 day, 4 hydrogel samples were harvested
as reference condition (calibrator) samples for gene expression. For the rest of samples,
culture media was switched to osteogenic differentiation media and cultured for 7, 14, 21,
and 28 days. At each time point, four hydrogel samples were harvested (n=4), manually
homogenized, lysed with 500 µL of RLT buffer (Qiagen, Valencia, CA) at room
temperature, and stored at -80⁰C freezer. After thawing and centrifugation at 13,000 g for
15 minutes at 4⁰C, supernatant was collected for analysis. Total RNA was isolated using
the Qiagen RNeasy mini kit (Qiagen) and treated with Turbo DNA-free DNase I Kit (Life
Technologies) to remove trace amounts of genomic or plasmid DNA. cDNA was
synthesized using 1 µg of total RNA from each sample as template using Retroscript Kit
(Life Technologies) and Rotorgene 3000 light thermal cycler (Corbett Research,
Mortlake, NSW, Australia). Real-time RT-PCR was performed with Quantitect SYBR
green PCR Kit (Qiagen) using custom-designed primers (Table 4.1). Relative gene
expression levels were calculated using ΔΔCt method with using β-2-microglobulin
(β2MG) as an internal control and the day 1 static samples as reference condition
(calibrator) [221]. The following PCR parameters were utilized: 95°C for 90 second
followed by 45 cycles of 95°C for 30 seconds and 55°C for 60 seconds.
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Target gene

Sense primer

Antisense primer

RUNX2

5’-CGAATGGACTATCCAGCCAC-3’

5’-TCCACTCTGGCTTTGGGAAG-3’

Collagen I

5’-TGCTGGTGCTCCTGGTACTC-3’

5’-TCCAGAGGGACCTTGTTTGC-3’

SP7

5’-TTCACTATGGCTCCAGTCCC-3’

5’-GAGTACGGCTTCTTTGTGCC-3’

Al-P

5’-ACCGAGATACAAGCACTCCC-3’

5’-TCACGTTGTTCCTGTTCAGC-3’

IBSP

5’-GGGAGTACGAATACACGGGC-3’

5’-TAGCCATCGTAGCCTTGTCC-3’

BGLAP

5’-GCGCTACCTGTATCAATGGC-3’

5’-TCCTGAAAGCCGATGTGGTC-3’

β2MG

5’-TGTGCTCGCGCTACTCTCTC-3’

5’-CGGATGGATGAAACCCAGAC-3’

Table 4.1 Target genes and primers for real time RT-PCR analysis.
4.2.7 Calcium and collagen staining
Encapsulated hMSCs were cultured with osteogenic supplements for 7, 14, 21,
28, and 35 days as described above, then fixed with 4% paraformaldehyde. Fixed
hydrogels were gradually infiltrated by OCT (Optimal Cutting Temperature) compound
(Sakura Finetechnical, Torrance, CA) by varying concentration of OCT in 1X PBS
solution (increasing concentration from 25 to 100% OCT). Samples in OCT were snapfrozen using liquid N2, then sectioned using Leica CM 1950 cryostat for desired
thickness. Calcium on 6 µm sections was visualized using von Kossa (Poly Scientific,
Bay Shore, NY) with Safranin O counter stain (Acros Organics) and Alizarin red S
(Acros Organics) staining. 15 µm sections were stained for collagen using aniline blue
(Poly Scientific). Stained sections were imaged using Nikon UZ-100 widefield
microscopy.
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4.2.8 Calcium quantification
Both acellular and hMSC encapsulated hydrogels were cultured with osteogenic
supplements for 7, 14, 21, 28, and 35 days as described above. 4 samples from each
group were harvested, then washed twice with 1X PBS, frozen at -80⁰C overnight, and
lyophilized using Labconco Freezone 4.5 freeze dryer. Dry weights of samples were
measured. Then samples were acid hydrolyzed at 90⁰C in 1 mL of 6 N Ultrex HCl
(Fisher Scientific, Pittsburgh, PA) overnight, dried under continuous stream of nitrogen
gas (Airgas National Welders, Atlanta, GA), re-dissolved with diluted 0.01 N Ultrex HCl
solution (Fisher Scientific) and centrifuged at 12,500 rpm to remove undissolved
impurities. Sample supernatants were diluted either 100 or 200 times volume with 0.5%
w/v lanthanum oxide (Alfa Aesar) in 0.3 N Ultrex HCl solution (Fisher Scientific).
Calcium concentrations of samples were measured using Perkin Elmer AAnalyst 200
atomic absorption spectrometer and normalized by dry weight of each sample previously
measured. Absorbance reading was converted to calcium concentration based on calcium
standard curve.
4.2.9 Statistical analysis
Quantitative data for calcium quantification, Al-P activities and osteogenic gene
expression by RT-PCR were compared by ANOVA using Tukey’s method for post-hoc
comparisons (one-way ANOVA followed by Bonferroni’s multiple comparison test). p
values < 0.05 were considered to be statistically significant. All quantitative data are
presented as mean ± standard deviation.
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4.3 Results
4.3.1 Alkaline phosphatase activity
hMSCs were encapsulated within semi-IPNs and cultured in the presence of
osteogenic supplements for 28 days. Total protein assay results indicated there was no
significant increase in protein level after day 7 in culture (data not shown here). Alkaline
phosphatase (Al-P) activity increased over time in culture, with levels measured at days
21 and 28 significantly higher than day 7 (Figure 4.1). However, the normalized Al-P
level of day 14 was not significantly different from day 21 and 28 (p<0.05).

Figure 4.1 Alkaline phosphatase activity normalized by total protein concentration of
hMSCs encapsulated in semi-IPNs at different time points during culture in the presence
of full osteogenic supplements, *=p<0.05 relative to day 7.
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4.3.2 Osteogenic gene expression
hMSC mRNA expression levels of several genes related

to osteogenic

differentiation were examined after 7, 14, 21, and 28 days of culture with osteogenic
supplements. In general, hMSCs exhibited significantly increased expression of all genes
examined at day 7 relative to control at day 0 (Figure 4.2). Expression levels of osterix
(SP7, Figure 4.2B), integrin-binding sialoprotein (IBSP, Figure 4.2D), and collagen type
I (Figure 4.2E) significantly decreased at later time points beyond day 7. In case of runtrelated transcription factor 2 (RUNX2, Figure 4.2A) and osteocalcin (BGLAP, Figure
4.2F), increased gene expression levels relative to the day 0 control were maintained
throughout the differentiation period.

Interestingly, expression levels of alkaline

phosphatase (Al-P) were significantly increased over time up to day 21 and later
decreased at day 28. However, it still maintained higher level of gene expression
compared to day 0 (Figure 4.2C).
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Figure 4.2 mRNA expression levels of RUNX2 (A), osterix (SP7) (B), alkaline
phosphatase (C), bone sialoprotein (IBSP) (D), collagen type I (E), and osteocalcin
(OCN) (F) at different time points during culture in the presence of full osteogenic
supplements. *=p<0.05 relative to day 0 control, #=p<0.05 and +=p<0.05 between
groups.
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4.3.3 hMSC morphology encapsulated in semi-IPN under osteogenic differentiation
condition
hMSCs were homogeneously encapsulated in photopolymerized 6% w/v PEGdAs
(12.5% PEG-bis-AA, 37.5% PEG-bis-AP, 50.0% PEG-bis-AB) / 0.36% w/v HA semiIPNs and cultured in full osteogenic media for 35 days. The selected semi-IPNs
supported the survival and spreading of hMSCs. After 21 days in culture, the semi-IPNs
showed increasing macroscopic opacity and encapsulated cells had spread and begun to
form a connected network (Figure 4.3A and B). The extensive mineralization in semiIPNs after 28 days of culture (Figure 4.3C) limited the ability of the confocal laser to
penetrate into the 3D structure, resulting in imaging only a limited number of cells
(Figure 4.3D).
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Figure 4.3 Macroscopic images of hMSC encapsulated 6% w/v PEGdAs / 0.36% w/v
HA semi-IPNs after 21 days in culture (A), and 28 days in culture (C), confocal
microscopy images of actin-stained hMSC encapsulated in semi-IPNs at 200 mm z-depth
after 21 days in culture (B), and 28 days in culture (D), scale bar = 100 µm.
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4.3.4 Collagen deposition and calcification in hMSC encapsulated semi-IPNs
Collagen deposition was modest at day 7 and then increased substantially after 21
days in culture (Figure 4.4A-C). Both calcium staining images (Figure 4.4G-I) showed
that mineralization increased with the time in culture, similar to observations of collagen
staining. Both collagen and calcium were homogeneously deposited throughout the entire
volume of hydrogels.

Figure 4.4 Histological sections of semi-IPNs with encapsulated hMSCs stained with
aniline blue for collagen (A-C), von Kossa for calcium (D-F), and Alizarin red S for
calcium (G-I) after 7, 21, and 35 days in culture, scale bar = 100 µm.
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4.3.5 Quantitative calcification
In order to determine the contribution of non-physiological calcification, acellular
semi-IPNs were included in the study as a negative control. As an additional control,
semi-IPNs with encapsulated hMSCs were cultured without dexamethasone to investigate
spontaneous osteogenic differentiation in the absence of a specific osteoinductive
stimulus. Encapsulated hMSCs in full osteogenic media (OB) showed significantly
increased calcification over time (Figure 4.5). Calcification in the experimental group
was also significantly higher than both control groups at all (time) points. The acellular
control group showed only a modest level of non-specific calcification. The control group
without dexamethasone also exhibited minimal calcification through day 21, but
significantly higher levels of calcium at days 28 and 35 relative to the acellular group.
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Figure 4.5 Calcium content measured in semi-IPN hydrogels normalized to sample dry
weight. All samples were cultured in full medium with osteogeneic supplements
(ascorbic acid-2-phosphate, betaglycerophosphate, and dexamethasone) except w/o dex
where dexamenthasone was omitted. Only statistical analyses for OB group shown here
for graphical clarity, #=p<0.05 between groups.
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4.4 Discussion
This study was designed to both qualitatively and quantitatively asses the ability
of selected semi-IPNs to support osteogenic differentiation of encapsulated hMSCs. It
was previously shown that, by the formation of HA-enriched zones from polymerizationinduced phase separation, semi-IPNs composed of hydrolytically degradable PEG
diacrylates, acrylate-PEG-GRGDS and native HA support rapid 3D cell spreading and
migration in a hyaluronidase-dependent manner. PEGdA/HA semi-IPNs were also able to
support cell spreading at relatively high levels of mechanical properties (~10 kPa elastic
modulus) compared to alternative hybrid hydrogels as shown in Chapter 3. This elastic
modulus value was previously reported as optimal for osteogenic differentiation in threedimensional (3D) culture [8]. In addition, the initial matrix stiffness is important as
hMSCs are no longer reprogrammable once they have committed to the lineage specified
by matrix elasticity after the initial week in culture [142]. As shown in Chapter 3,
selected semi-IPNs maintained about 70% of initial mass after 1 week of culture while it
provided the space for cell spreading.
To test of its feasibility as a scaffold for cell transplantation and 3D in vitro
culture platform, hMSCs were photo-encapsulated within 6% w/v PEGdA/ 0.36% HA
semi-IPNs with previously selected compositions (12.5% PEG-bis-AA, 37.5% PEG-bisAP, and 50.0% PEG-bis-AB) and cultured under osteogenic differentiation conditions for
up to 35 days. Confocal microscopy images showed spindle- shaped morphology of
hMSCs encapsulated within semi-IPNs. Initial cell spreading occurred within the space
filled with HA where HAse degrades first [187]. Cell spreading was supported in selected
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semi-IPNs and could be observed till day 28. At later stage of culture (day 35), confocal
scanning was hindered by deposited calcium (image not shown). Since hMSC viability
and spreading are dependent on 3D network degradability, this enzymatic degradation
positively affected long-term survival of transplanted stem cells and enhanced osteogenic
differentiation and mineralization [9,170,217,218].
Alkaline phosphatase (Al-P) activity increased over time in 3D culture. Other
research groups have also reported similar trends in Al-P activities for encapsulated
hMSCs and dependency of differentiation on matrix degradability. Anderson and coworkers observed increased Al-P activity over time and over increasing MMP sensitive
peptide concentration in thiol-ene hydrogels over 21 days of culture, suggesting
osteogenic differentiation was influenced by network degradability [170]. Benoit and coworkers also reported the increasing trend of Al-P activity in 3D culture and its
dependency on copolymer network composition (i.e. degradation rate). The Al-P activity
increased over time and with increased degradability along with increased osteopontin
and type I collagen expression [218]. Temenoff and co-workers reported different
biphasic behavior (lowest Al-P activity at day 14 for all conditions) of Al-P activities in
3D MSC culture using oligo(poly-(ethylene glycol) fumarate) hydrogel [222].
When gene expression related to osteogenic differentiation of MSCs in 3D
hydrogel culture was investigated and compared to other 3D culture studies, the temporal
patterns and gene expression levels are not consistent with one another due to the fact
that gene expression of encapsulated hMSCs depends on the surface characteristics
(topography, chemistry, surface energy, and interplay of stiffness and adhesion ligand

81

presentation) of materials and changed accordingly [215,218,223–225]. Protein related to
ECM maturation and bone cell phenotype, alkaline phosphatase (Al-P) gene expression
of hMSCs encapsulated within semi-IPNs followed similar trend to 2D monolayer
culture, with a peak around day 12 to 18 and subsequent decrease [220,226]. Early
marker genes associated with extracellular matrix (ECM, type I collagen) and master
gene controlling MSC differentiation into pre-osteoblast (runt-related transcription factor,
RUNX2) exhibit different patterns of expression from each other. Collagen type I
reached its peak expression level at day 7 and gradually decreased during subsequent
stages of differentiation, which followed general profile of monolayer culture reported by
Stein et al. and Born et al., but different from increasing trend in 3D culture reported by
Benoit and co-workers [218,220,226]. However, RUNX2 maintained relatively similar
gene expression level (no significant difference after day 7) throughout the entire
differentiation period, exhibiting similar pattern to hMSCs cultured within soft (100 Pa)
PEG-silica hydrogel (control to 2D monolayer culture) reported by Pek and co-workers,
but different from the profile reported by Jha and co-workers. (up-regulated at day 21
compared to day 7 gene expression level) [216,227]. Osterix (SP7), which is
transactivated by Runx2, regulates bone formation and plays a role in terminal maturation
for osteoblast differentiation. hMSCs encapsulated within semi-IPNs showed early upregulation of osterix at day 7, suggesting early differentiation of pre-osteoblasts to
osteoblasts [228,229]. Osteocalcin (OCN), a major non-collagenous protein related to
ECM mineralization, maintained high expression level after day 7 for hMSCs
encapsulated within semi-IPNs, different from 2D monolayer pattern (up regulation
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around days 16-20), but similar to one in 3D culture reported by Pek and co-workers
[220,226,227]. Bone sialoprotein (IBSP), a major component of ECM, has been known to
be a potent nucleator for hydroxyapatite formation and important for the initiation of
bone mineralization. Early up-regulation of IBSP suggested early initiation of bone
mineralization and the adhesion of (pre)osteoblasts to mineralized matrix [230]. Overall,
hMSCs encapsulated within semi-IPNs showed similar ECM production process
(collagen type I, alkaline phosphatase, osteocalcin, and IBSP) and relatively up-regulated
and rapid osteoblast differentiation process (RUNX2 and SP7) compared to 2D
monolayer culture reported by Stein and co-workers [220].
After 21 days of culture, calcification could be observed macroscopically and
rapidly progressed over time. Although there were varying degrees of decrease in total
volume of hydrogels (images not shown), hydrogels remained mechanically intact until
the end of culture (day 35). Over a comparable timeframe, acellular semi-IPNs
completely degrade in normal culture conditions as shown in Chapter 3, suggesting that
the hybrid hydrogel network was replaced by newly formed mineralized tissue. As for
acellular semi-IPNs, although they swelled more (i.e. weaker and increased volume of
hydrogels) compared to semi-IPNs with hMSC, they maintained the structural integrity
till day 35 by non-physiological calcium deposition. This observed calcification also
coincided with histology and calcium quantification results (rapid increase in
calcification after 21 days). The degree of mineralization increased for all control and
experimental groups over time. However the degree and the rate of calcification was
different from one another. Two control groups reached calcification plateau at day 21

83

(acellular hydrogel) and 28 (hydrogels in osteogenic media without dexamethasone)
while experimental group showed substantial increase after day 21 as also shown in
histology. Compared to other studies, the degree of mineralization (deposited calcium
level) in semi-IPNs is relatively higher than those reported elsewhere [170,222]. Calcium
ion transport would not be diffusion limited as IgG has been shown to be readily released
from PEGdA hydrogels [188]. Additionally, it was hypothesized that Hase-mediated
degradation at the early stage of cell culture could expand pore size in semi-IPNs and
promote ion diffusion inside hydrogel network. Acellular control hydrogels showed little,
but obvious calcium deposition, suggesting that non-physiological calcium deposition
was still possible with full osteogenic media. Although it has been known that
biomineralization in (acelluar) organic matrix is slow and difficult to control due to pore
size and dense network structure, the process works relatively better in soft polymer with
very large equilibrium water contents [231–233]. Comparably, encapsulated hMSCs and
deposited collagen (produced from cells) acted as nucleation site for calcium ion and
resulting in increased calcification / biomineralization [233,234]. Cell encapsulated
hydrogels in osteogenic media without dexamethasone showed higher calcium deposition
than acellular hydrogels, but significantly less calcium contents compared to hydrogels in
full osteogenic media, indicating that semi-IPN mineralization was primarily attributable
to

dexamethasone-induced

hMSC

differentiation

and

spontaneous

osteogenic

differentiation could be achieved even in the absence of a specific osteoinductive
stimulus (i.e. absence of dexamethasone supply).
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4.5 Conclusions
This study demonstrated that PEGdA blend/HA semi-IPNs supported initial
hMSC survival, spreading, and long term osteogenic differentiation. HA enriched zone
from phase separation between the two components occurring during photocrosslinking
provided the space for initial cell spreading via enzymatic degradation. Osteogenic
differentiation of hMSCs encapsulated within semi-IPNs provided detailed gene
expression profile in 3D culture, which followed relatively faster osteoblast maturation
process and similar gene expression profile of mineralization process compared to 2D
monolayer culture reported in the literature. The orchestrated prolonged degradation
resulted in physiological collagen and calcium deposition during hMSC differentiation
and network remodeling over 35 days in culture. These experiments suggest that
PEGdA/HA based semi-IPNs are promising cell carrier materials for stem cell therapy
applications. Ongoing studies are examining covalent conjugation of bioactive molecules
to the HA component of these networks for sequestration and cell-mediated release
during network remodeling and applications in bone tissue engineering.
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CHAPTER FIVE
HYBRID HYDROGEL / HYDROPHOBIC
NANOPARTICLE COMPOSITES FOR ENHANCED
EXTRACELLULAR MATRIXS DEPOSITION

5.1 Introduction
Following tissue injury, the coagulation cascade produces a blood clot consisting
predominantly of fibrin with smaller amounts of other plasma proteins such as fibronectin
and growth factors released from damaged platelets. The fibrin clot serves as a
hemostatic plug and a provisional matrix for tissue repair. During the proliferative phase,
fibroblasts in healthy tissue adjacent to the wound site divide and migrate into the fibrin
clot, remodeling it through a combination of cell-mediated proteolytic degradation and
synthesis and organization of new extracellular matrix [235,236]. Briefly, ECM assembly
in vivo is initiated by ECM glycoproteins binding to cell surface receptors, such as
fibronectin (FN) dimers binding to α5β1 integrin receptors. Receptor binding stimulates
FN self-association mediated by the N-terminal assembly domain and organizes the actin
cytoskeleton to promote cell contractility [237]. FN conformational changes (compact to
extended) induced by cellular traction expose additional cryptic integrin binding domains
[29]. Cells use collagen V and XI to nucleate collagen fibrils, and FN and integrins to
specify the assembly site at the cell surface [238–240].
Most tissue engineering and regenerative medicine strategies involve the use of a
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polymeric scaffold as a transient structure to support cell adhesion, migration,
proliferation, and differentiation that gradually degrades and is replaced by newly
synthesized matrix. Much recent attention has focused on the use of hydrogel scaffolds
due to their ability to be delivered to the injury site by minimally invasive procedures and
crosslinked in situ using mild chemistries compatible with the encapsulation of living
cells and bioactive molecules. With the exception of protein-based hydrogels (collagen,
fibrin, etc.), the vast majority of hydrogels are based on hydrophilic polysaccharides and
synthetic polymers [6,11,44,45]. One shared characteristic of these materials is a very
low capacity for protein binding, rendering them ‘blank slates’ that do not interact with
cells without the incorporation of exogenous cues such as RGD peptides to promote cell
adhesion [45]. In fact, the most widely studied of these polymers, polyethylene glycol
(PEG), has been extensively applied as a surface coating specifically intended to block
protein adsorption and cell adhesion [162,241,242]. Although the most abundant ECM
proteins, collagen type I and II spontaneously form fibrils in vitro by entropy-driven selfassembly [243], the hydrophilic nature of hydrogel network hinders cell derived matrixprotein binding, resulting in diffusional loss to the liquid phase [164,244]. This
diffusional loss of ECM proteins can to some degree be compensated by increased ECM
production through sequestration of proteins by specific hydrogel chemistries
[101,245,246], increasing encapsulated cell density [247], and controlled release or
covalent immobilization of growth factors [148,248]. As an alternative approach to this
strategy of promoting increased ECM production within the hydrogel scaffolds,
incorporation of collagen mimetic peptide sequence into PEG based hydrogel showed
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increased collagen deposition inside scaffold [249]. However, this approach would not be
cost effective because relatively large scale production is required for practical clinical
applications.
Previously, the inclusion of biodegradable polymer spheres or fibers with
hydrophobic surfaces showed increased volume of cell-derived matrix accumulation
compared to tissues formed from cells alone when used as cell transplant scaffolds [250–
252]. Based on these findings, it was hypothesized that the incorporation of
biodegradable hydrophobic nanospheres within hybrid hydrogel networks could provide
binding sites for secreted ECM and serve as nucleation sites for matrix assembly. In this
study, submicron size (500 to 900 nm diameter) poly-L-lactic acid (PLLA) spheres were
fabricated and incorporated into PEGdA/hyaluronic acid (HA) semi-IPNs described in
Chapters 3 and 4. Normal human dermal fibroblasts (NHDF) were encapsulated within
semi-IPNs with PLLA nanospheres (semi-IPN composites) and cultured under ascorbatesupplemented growth condition for 35 days to evaluate the effect of incorporation of
PLLA nanospheres on matrix protein (collagen) deposition. Experimental groups with
PLLA nanospheres exhibited higher accumulation of collagen than control (semi-IPNs
without PLLA nanospheres) qualitatively (histology) and quantitatively (hydroxyproline
assay). Mechanical properties obtained from tensile testing and swelling revealed the
effect of inclusion of nanospheres on structural integrity of semi-IPNs. Confocal imaging
and AFM force indentation showed the changes in elastic modulus profile on surface of
semi-IPNs.
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5.2 Materials and Methods
5.2.1 Synthesis of PEGdA macromers with ester linkage containing variable alkyl
spacers
Three PEGdAs with varying susceptibility to hydrolytic degradation were
synthesized by a two-step process. First, PEG (Fluka, MW 4000) was reacted with
chloroacetyl chloride, 2-chloropropionyl chloride, or 4-chlorobutyryl chloride and then
the resulting intermediate products were reacted with sodium acrylate to obtain PEG-bisAA, PEG-bis-AP, or PEG-bis-AB, as previously described in Chapter 3. All samples
achieved acrylation efficiencies greater than 92.5%, determined from 1H-NMR (Bruker
300 MHz, CDCl3) spectra.
5.2.2 Preparation of poly-L-lactic acid nanospheres
Poly-L-lactic acid (PLLA, NatureWorks, Minetonka, MN) spheres with
nanometer size range (500 to 950 nm diameter) were prepared by the modified single
emulsion technique [253]. Briefly, PLLA particles were dissolved (50 mg/mL) in
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) solution and mixed with
deionized water at 2:1 (PLLA solution:H2O) ratio. Then PLLA solution was quickly
sonicated for 30 seconds at 10 watt intensity using Sonic Ruptor 400 Ultrasonic
Homogenizer (Omni International, Kennesaw, GA) to produce PLLA nanospheres.
Solutions were continuously stirred for 4 hours to remove excessive DMF. Large size
PLLA particles were removed using cell strainer with 40 micron size mesh (Fisher
Scientific, Pittsburgh, PA). Filtered solution containing small size PLLA nanospheres
was centrifuged at 4500 g for 10 minutes and the supernatant discarded. Nanospheres
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were re-suspended in deionized water and mean particle size distribution was measured
using 90 Plus particle size analyzer (Brookhaven Instruments Corporation, Holtsville,
NY). PLLA spheres with target size distribution (ca. 500 nm to 1 µm diameter) were
recovered and exposed to two additional washing steps (re-suspension with deionized
water and recovery by centrifugation at 4500 g for 10 minutes). PLLA nanospheres were
later freeze-dried using Labconco Freezone 4.5 lyophilizer and dry weight was measured.
Dried spheres were re-suspended with deionized water, centrifuged at 4500 g, resuspended with 70% ethanol for sterilization for 30 minutes, and washed with 1X PBS
solution three times prior to encapsulation.
5.2.3 Semi-IPNs and semi-IPN composites photopolymerization
Hyaluronic acid (Lifecore Biomedical, Chaska, MN) with 1.5 MDa molecular
weight stock solution (1.75% w/v), PLLA nanosphere stock solution (100 mg/mL) and
PEGdA (30% w/v) stock solutions were prepared in 1X-PBS (0.1M, pH 7.4). Gel
precursor solutions (total 250 µL in 1X PBS) were prepared containing 6% w/v PEGdA
blend (12.5% PEG-bis-AA, 37.5% PEG-bis-AP, and 50.0% PEG-bis-AB) and 0.36% w/v
HA, and 2-hydroxy-1-[4-(hydroxyethoxy) phenyl]-2-methyl-1-propanone (I-2959, BASF,
Florham Park, NJ, 0.1% w/v), and varying amounts of PLLA nanospheres (0, 10, 20, 25,
50 mg/mL). Sample volumes (55 µl) were pipetted in between glass separated by 1 mm
Teflon spacers and exposed to low intensity UV illumination (365 nm, 10 mW/cm2,
Black-Ray B100-AP, Upland, CA) for 5 minutes on each side of the disc.
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5.2.4 Hydrogel characterization; swelling test, mechanical properties and hydrophobic
domain visualization
Semi-IPNs and semi-IPN composites (6% w/v PEGdAs with 0.36% HA
containing PLLA nanospheres with 10 mg/mL and 20 mg/mL concentration respectively)
were photopolymerized as described above (n=6/group). Circular hydrogel samples
(1mm thick, 8mm diameter) were punched out using General Hollow Steel Punches
(General Tools MFG., New York, NY) and equilibrated in distilled water for 24 hours to
remove any unpolymerized macromer. Samples were lyophilized and dry weights (Dw1)
were measured. The gels were immersed in 1X PBS and allowed to swell for 24 hours in
order to record the wet weights (Ww). Samples were lyophilized again and second dry
weights (Dw2) were measured. The gel content (Dw1 / Dw2), equilibrium water content
((Ww-Dw2) / Ww2), and mass swelling ratio (Ww / Dw2) were calculated as previously
described [Martens PJ Biomacromolecules 2003, Lin CC Adv Drug Deliv Rev 2006].
The weights of PLLA nanospheres in semi-IPN composite samples were subtracted in all
swelling calculation based on the volume of semi-IPNs and concentration of PLLA
nanospheres.
Semi-IPNs and semi-IPN composites with same composition as in swelling tests
were prepared and cut into custom made dumbbell shaped samples with 30 mm gauge
length, 5 mm width, and 1 mm thickness. The samples (n=3/group) were subjected to
75% strain at 30 mm/min using an MTS Synergy 100 (MTS Systems Corporation) at
room temperature.
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Hydrophobic surfaces within semi-IPNs and semi-IPN composites with 10 or 20
mg/ml PLLA nanosphere concentrations were visualized using histological staining.
Semi-IPNs and semi-IPN composites were gradually infiltrated by OCT (Optimal Cutting
Temperature) compound (Sakura Finetechnical, Torrance, CA) by varying concentration
of OCT in 1X PBS solution (increasing concentration from 25 to 100% OCT). Samples
in OCT were snap-frozen using liquid N2, then sectioned using Leica CM 1950 cryostat
at desired thickness. Hydrophobic domains on 10 µm sections were stained using Sudan
black B (Acros Organics with other supplies from Poly Scientific, Bay Shore, NY).
Stained sections were imaged using Nikon UZ-100 widefield microscopy.
5.2.5 In vitro cell culture
Normal human dermal fibroblasts (NHDF, Lonza, Walkersville, MD) were
cultured in 75cm2 tissue culture flasks at 37⁰C with 5% CO2 supply. Cells were cultured
in DMEM/F-12 (50/50 mix) with L-glutamine media (Mediatech, Manassas, VA)
supplemented with 10% (v/v) bovine growth serum (Thermo Scientific) and 50U/mL
penicillin and 50µg/mL streptomycin (Mediatech). Medium was changed every 2 days
and cells were passaged at a 1:3 ratio for cell expansion after reaching 85 to 90%
confluence. All encapsulation studies were done with cells between passages 5 and 6.
5.2.6 NHDF encapsulation in semi-IPNs and semi-IPN composites
Hyaluronic acid with 1.5 MDa molecular weight stock solution (1.75% w/v),
PLLA nanosphere (100 mg/mL) stock solution, and PEGdA (30% w/v) stock solutions
were prepared in 1X-PBS (0.1M, pH 7.4). Acryl-PEG-GRGDS was synthesized by
conjugating GRGDS peptide (Bachem, Torrance, CA) to acryl-PEG-NHS (Jenkem,
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Beijing, China) as previously described [169]. Gel precursor solutions (250 µL in 1X
PBS) were prepared containing 6% w/v PEGdA blend (12.5% PEG-bis-AA, 37.5% PEGbis-AP, and 50.0% PEG-bis-AB), 0.36% w/v HA, acryl-PEG-GRGDS (1µmol/mL),
0.1% w/v I-2959 initiator (BASF in 70% ethanol solution), PLLA nanosphere (0, 10, 20
mg/mL as final concentration each) and NHDF (final concentration at 10.0×106
cells/mL). Prior to cell addition, all other components were mixed and vortexed to
uniformly disperse PLLA nanospheres. NHDF were then added and uniformly dispersed
within the gel precursor solution by manual pipetting. Sample volumes (55 µl) were
pipetted in between glass coverslips separated by 1 mm Teflon spacers and exposed to
low intensity UV light for 5 minutes on each side of the disc. Semi-IPNs and semi-IPN
composites with encapsulated cells were cultured in growth media with addition of 1mM
ascorbic acid-2-phosphate (Sigma-Aldrich) in 35 mm diameter Petri dishes (BD, San
Jose, CA) with 3mL culture medium.
5.2.7 Monitoring of encapsulated NHDF morphology
Semi-IPNs and semi-IPN composites (10 and 20 mg/mL PLLA nanosphehere
concentrations) with encapsulated NHDF (n=2/time point in each group) were cultured in
35mm Petri dishes for 7, 21 and 35 days, then fixed with 4% paraformaldehyde (Alfa
Aesar, Ward Hill, MA), permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and
stained with Alexa Fluor 594-phalloidin (Life Technologies). The morphologies of
encapsulated cells were imaged using a Nikon Eclipse Ti confocal microscopy at various
z-depths.
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5.2.8 Surface characterization by AFM
Semi-IPNs and semi-IPN composites (10 and 20 mg/mL PLLA nanosphehere
concentrations) with encapsulated NHDF (n=3/time point) were cultured in 35mm Petri
dishes for 7, 21 and 35 days. Acellular semi-IPNs and semi-IPN composites with 10 and
20 mg/mL PLLA nanosphere concentrations were also prepared as day 0 samples. At
each time point, gels were washed with 1X PBS and tested for nano-indentation in 1X
PBS immersion using a Molecular Force Probe 3D AFM (MFP-3D, Asylum Research,
Santa Barbara, CA, USA) using silicon nitride cantilevers (NanoAndMore USA, Lady’s
Island, SC, 0.08 N/m spring constant, 5.0 µm tip radius, and 37.7 kHz resonance
frequency) at room temperature. The elastic moduli of the semi-IPNs and semi-IPN
composite surfaces were calculated by fitting the nano-indentation data with Hertz model
[254,255]. Five indentation curves were collected at random positions of each sample.
5.2.9 Collagen histological staining
Deposited collagen within semi-IPNs and semi-IPN composites (10 and 20 mg/ml
PLLA nanospheres) with encapsulated NHDF was visualized by histological staining.
Semi-IPNs with encapsulated NHDF were cultured in 1mM ascorbic acid-2-phosphate
supplemented growth media for 7, 21 and 35 days as described above, then fixed with 4%
paraformaldehyde, gradually infiltrated by OCT, snap frozen with liquid N2, and then
cryosectioned as previously described in detail (5.2.4). 15 µm sections were stained for
collagen using aniline blue (Poly Scientific). Stained sections were imaged using Nikon
UZ-100 widefield microscopy.
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5.2.10 Scanning electron microscopy imaging
Extracellular matrix deposition on semi-IPNs and semi-IPN composites surface
was studied using scanning electron microscopy (SEM; Hitachi S-4800, Japan). 15 µm
thick cryosections from each semi-IPNs and semi-IPN composites (10 and 20 mg/mL
PLLA nanospheres) group with encapsulated NHDF at day 35 were dehydrated through
grade series of

ethanol solutions and hexamethyldisilazane (United Chemical

Technologies, Bristol, PA), sputtered with gold for 2 minutes in prior to imaging.
5.2.11 Collagen quantification
Semi-IPNs and semi-IPN composites (10 and 20 mg/mL PLLA nanospheres) with
encapsulated NHDF were cultured in growth media supplemented with ascorbic acid-2phosphate (Sigma-Aldrich) for 7, 21, and 35 days. 12 samples from each group at each
time point were harvested, washed twice with 1X-PBS, collected in three 1.7 mL
centrifuge tubes (n=4 in each tube), and stored in -80⁰C in deep freezer. Samples were
thawed, manually homogenized, lysed with 0.1% w/v Triton X-100 (Sigma-Aldrich),
sonicated for 10 minutes in ice bath, and centrifuged at 10,000 g at 4⁰C for 10 minutes.
Supernatants were recovered and the amount of total DNA measured using Pico-green
assay (Life Technologies) according to manufacturer’s instruction. The remaining sample
volumes were mixed with equal volumes of 12N hydrocholoric acid (Fisher Scientific) to
have 6N as final HCl concentration and acid-hydrolyzed overnight at 120⁰C. The
digested products were centrifuged at 10,000 g for 10 minutes at room temperature and
supernatants were used for hydroxyproline assay. Briefly, hydroxyproline in acid
hydrolyzed samples was reacted with p-dimethylamino benzaldehyde and chloramine-T
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hydrate (both from Sigma-Aldrich). Absorbance was measured at 558 nm and
hydroxyproline concentration was calculated from a standard curve prepared with trans4-hydroxy-L-proline (Sigma-Aldrich). Total collagen content of the semi-IPNs was
estimated from hydroxyproline assay result based on the estimation that hydroxyproline
made up about 13.2% of the total collagen [256,257]. Total collagen amounts were
normalized by total DNA contents from Pico-green assay results.
5.2.12 Statistical analysis
Quantitative data were analyzed by ANOVA using Tukey’s method for post-hoc
comparisons (one-way ANOVA followed by Bonferroni’s multiple comparison test). p
values < 0.05 were considered to be statistically significant. All quantitative data are
presented as mean ± standard deviation.

5.3 Results
5.3.1 PLLA nanosphere production
Various intensities and exposure times of sonication were tested to increase the
product yield of PLLA nanospheres with mean size distribution ranging from 500 to 900
nm diameter. Sonication intensity at 10 Watts for 30 seconds was identified as the
optimal condition for production of PLLA nanospheres in this size range. PLLA
nanosphere yield was 16.2% w/w (dry weight of product/dry weight of raw PLLA
particulate). Most of yield loss occurred through the removal of large size spheres (larger
than 50 µm size microspheres) using the cell strainer.
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5.3.2 Hydrogel characterization; swelling and mechanical properties of semi-IPNs
containing various amounts of PLLA nanospheres and hydrophobic domain visualization
The effect of PLLA nanosphere incorporation on semi-IPNs physical properties
was analyzed by measuring swelling and elastic modulus. Semi-IPNs containing 10
mg/mL PLLA nanospheres did not exhibit any significant differences in gelation
efficiency and swelling relative to controls without PLLA nanospheres (Figure 5.1).
When the PLLA nanosphere concentration was raised to 20 mg/ml, gelation efficiency
significantly increased and swelling significantly decreased relative to both composites
containing 10 mg/ml and the control gels without PLLA nanospheres. Figure 5.2 shows
the elastic modulus of PEGdAs/HA semi-IPNs containing 0 (control), 10, and 20 mg/mL
PLLA nanospheres. Addition of 20 mg/ml PLLA nanospheres significantly increased the
elastic modulus of semi-IPNs. The incorporation of higher amounts of PLLA
nanospheres (more than 25 mg/mL) resulted in breakage of sample during tensile test,
suggesting the microsphere content had reached a level where it compromised the
mechanical integrity of the semi-IPN network. The hydrophobic domains within 10 µm
section of semi-IPNs were visualized by Sudan black B staining. Hydrophobic surface
was stained black showing the hydrophobic domain distribution within the entire volume
of semi-IPN control (no PLLA nanospheres, semi-IPNs) and semi-IPN/PLLA nanosphere
composites (Semi-IPN composites) as shown in Figure 5.3.
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Figure 5.1 Swelling test results of 6% w/v PEGdA/0.36% w/v HA semi-IPNs containing
varying amounts of PLLA nanospheres; gel content (A), equilibrium water content (B),
and mass swelling ratio (C). *=p<0.05 relative to PEGdA/HA semi-IPNs (no
nanospheres) and #=p<0.05 between groups.
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Figure 5.2 Elastic modulus of 6% w/v PEGdA/0.36% w/v HA semi-IPNs containing
varying amounts of PLLA nanospheres. *=p<0.05 relative to PEGdA/HA semi-IPNs (no
nanospheres) and #=p<0.05 between groups.

Figure 5.3 Widefield microscopy images of Sudan black B stained cryosections of 6%
w/v PEGdAs / 0.36% w/v HA semi-IPNs containing 0 mg/mL (A), 10 mg/mL (B), and
20 mg/mL (C) PLLA nanospheres, scale bar = 500 µm.
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5.3.3 NHDF morphology on semi-IPNs and semi-IPN composite surfaces
Both semi-IPNs (no PLLA nanospheres) and semi-IPN composites (semi-IPNs
containing PLLA nanospheres) supported the survival and spreading of encapsulated
NHDF. NHDF morphology within semi-IPN composites was not imaged clearly because
PLLA nanospheres interfered with light penetration into the samples, resulting in
increased noise level in confocal image (not shown here). The only detectable difference
between groups in morphological development of NHDF was observed on sample
surfaces (z=0) at 7 days in culture. NHDF on semi-IPN composites showed increased cell
spreading and even dense network formation on the surface of semi-IPN composites with
20 mg/mL PLLA nanospheres (Figure 5.4).

Figure 5.4 Confocal microscopy images of NHDF on the surface of 6% w/v PEGdA /
0.36% w/v HA semi-IPNs (A) and semi-IPN composites containing PLLA nanospheres
at 10 mg/mL (B), and 20 mg/mL (C) concentration after 7 days in culture, scale bar = 100
µm.
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5.3.4 Monitoring changes in surface mechanical property using AFM nano-indentation
The changes in elastic modulus on the surface of semi-IPNs and semi-IPN
composites over entire time scale of cell culture were monitored using AFM nanoindentation technique (Figure 5.5). Elastic modulus values for acellular control semiIPNs were in close agreement with the values measured by tensile testing (Figure 5.2).
Interestingly, the surface elastic moduli values of acellular semi-IPN composites are
different from tensile testing values, 11.3 ± 0.49 kPa from tensile testing vs. 5.97 ± 0.09
kPa from AFM nano-indentation for acellular semi-IPN composites with 10 mg/mL
PLLA nanospheres. As for semi-IPN composites with 20 mg/mL PLLA nanospheres,
AFM nano-indentation results showed higher elastic modulus value (18.01 ± 2.57 kPa)
over one from tensile testing (12.5 ± 0.44 kPa). All three groups showed significant
decreases in surface elastic modulus at day 7 compared to acellular groups (day 0). In
case of semi-IPN composites with 20 mg/mL PLLA nanospheres, the value was an order
of magnitude lower. Then, all 3 groups exhibited similar surface elastic moduli values
(no significant difference) after 21 and 35 days in culture.
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Figure 5.5 Elastic modulus of the surface of acellular and NHDF encapsulated semiIPNs and semi-IPN composites over time obtained from AFM nano-indentation
technique. *=p<0.05 relative to semi-IPNs (no spheres) and #=p<0.05 between groups.
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5.3.5 Collagen deposition within NHDF encapsulated semi-IPNs and semi-IPN
composites
The effect of incorporation of PLLA nanospheres in semi-IPNs on collagen
deposition was visualized by histological staining and quantified by measuring total
collagen content. Semi-IPN composites showed more collagen deposition over semi-IPN
controls after 35 days in culture as shown in Figure 5.6. Aniline blue was used for
staining collagen. No other counter stain agent was used to visualize collagen around cell
(pericelluar region) as it could interfere the visualization. Within semi-IPNs and semiIPN composites, pericellular regions are stained darker (blue), indicating collagen
deposition around the cell. Also more collagen molecules were deposited on the surface
of semi-IPNs and semi-IPN composites.

Figure 5.6 Widefield microscopy images of NHDF encapsulated semi-IPN and semi-IPN
composite cryosections stained with aniline blue for collagen (stained blue) after 35 days
in culture; semi-IPNs (A), semi-IPN composites with 10 mg/mL (B), and 20 mg/mL (C)
PLLA nanosphere concentrations, scale bar = 500 µm.
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To confirm these histological results, total collagen amounts (estimated from
hydroxyproline assay results and then normalized by total DNA amounts in each sample)
deposited within semi-IPNs and semi-IPN composites were compared. Due to low
concentration of hydroxyproline within individual semi-IPNs and semi-IPN composite
sample (close to detection threshold), a total of 4 samples were hydrolyzed together for
each hydroxyproline assay (i.e. total 12 hydrogels were used for one time point in Figure
5.7). Collagen deposition in both semi-IPNs and semi-IPN composites did not show
significant difference between groups at day 7 and 21. Deposited collagen amounts were
significantly increased for all groups at day 21 in culture compared to day 7 groups. At
day 35 in culture, semi-IPN composites exhibited significantly increased collagen
deposition relative to semi-IPNs control (Figure 5.7).
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Figure 5.7 Total collagen amounts within semi-IPNs and semi-IPN composites over time
obtained from hydroxyproline assay and normalized by total DNA concentration from
Pico-green assay results. *=p<0.05 relative to total collagen measured at day 7 in each
group, +=p<0.05 relative to total collagen measured at day 21 in each group and
#=p<0.05 between groups.
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Scanning electron microscopy images also showed ECM deposition on the
surface of PLLA nanospheres (Figure 5.8 C through F) within semi-IPN composites
compared to semi-IPNs (Figure 5.8A and B). Although the mean size distribution was
submicron size (500 to 900 nm diameter), the diameters of PLLA nanospheres in SEM
images exhibited relatively larger size diameter due to aggregated nature of hydrophobic
particles inside hydrophilic hydrogel environment (Figure 5.8D and E) and deposited
ECM proteins on surface of PLLA nanospheres (Figure 5.8C and F).
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Figure 5.8 Scanning electron microscopy images of NHDF encapsulated within semiIPNs (A and B) and PLLA nanospheres within semi-IPN composites with 10 mg/mL (C
and D), and 20 mg/mL (E and F) PLLA nanosphere concentrations after 35 days in
culture.
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5.4 Discussion
Inside a successful cell transplantation hydrogel scaffold, encapsulated cells must
produce native ECM molecules to gradually replace the original polymer network as it
degrades. PEG-based hybrid hydrogel scaffolds have been widely investigated as
matrices for 3D cell culture and transplantation as PEG can be easily modified with
naturally derived molecules such as adhesion and MMP sensitive peptides [6,45,85].
Despite its many benefits, the original biomedical application of PEG was grafting to
other surfaces such as implant or prosthetics to create anti-fouling, protein-repellent
materials [162,241,242]. Therefore, PEG may not be a particularly effective material for
supporting ECM binding and assembly. Many research groups have also reported
diffusional loss of matrix protein produced by encapsulated cells in PEG based hydrogel
scaffolds as a consequence of PEG’s inability to bind these molecules [163–
165,244,258]. In this study, to avoid diffusional loss of ECM molecules produced from
encapsulated cells in hydrogel network, nanometer size range (500 to 950 nm diameter)
hydrophobic PLLA nanospheres were incorporated within semi-IPNs to promote matrix
protein deposition inside the network.
The incorporation of PLLA nanospheres affected physical properties of semiIPNs. Our first step was to encapsulate PLLA nanospheres (along with NHDF) and
confirm they were homogenously distributed (Figure 5.3 and 5.8). Interestingly, PLLA
nanospheres increased elastic modulus of semi-IPNs in a dose-dependent manner up to
20 mg/mL concentration range although it damaged the network structure over 25 mg/mL
concentration (breakage of sample during tensile testing) (Figure 5.2). Semi-IPN
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composites with 20 mg/mL PLLA nanospheres showed significantly increased gel
content and significantly decreased equilibrium water content and mass swelling ratio
relative to semi-IPNs control and semi-IPN composites with 10 mg/mL PLLA
nanosphere groups. This may be due to the increase in hydrophobicity of the network by
encapsulated PLLA nanospheres, which could be explained by the work done by
Sawhney and co-workers. They demonstrated that the addition (increase) of hydrophobic
PLA or PGA groups between central PEG block and terminal acrylate groups led to
micelle type conformational change. This change effectively increased the proximity of
acrylate groups, resulting in more rapid polymerization [259].
After day 7 in ascorbic acid-2-phosphate supplemented culture, encapsulated
NHDF showed different degree of spreading and network formation on the surface of
semi-IPNs and semi-IPN composites (z at 0 µm in confocal image in Figure 5.4). Cells
on semi-IPN composites showed increased cell spreading and network formation
compared to semi-IPNs control, consistent with previous reports of increased cell
spreading and network formation on stiffer surfaces [137,260,261]. The incorporation of
PLLA nanospheres provided localized stiffer surface (18.0 ± 2.6 kPa) than semi-IPNs
alone (10.9 ± 0.1 kPa) in case of semi-IPN composites with 20 mg/mL PLLA
nanospheres. At day 7 in culture, the elastic modulus of semi-IPN compoistes with 20
mg/mL surface was dramatically decreased from 18.0 ± 2.6 kPa to 0.53 ± 0.36 kPa
(Figure 5.5). This dramatic change reflected rapid network formation (followed by ECM
deposition), and was also visualized by confocal microscopy image (Figure 5.4). AFM
nano-indentation results showed biphasic behavior in elastic moduli values of semi-IPN
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composites with 20 mg/mL PLLA nanosphere surface. Between day 7 and 21, all
surfaces of semi-IPNs and semi-IPN composites groups were gradually covered by
cellular network and deposited matrix protein and elastic moduli values from AFM nanoindentation reached the plateau. After 21 days in culture, all surfaces formed dense
ECM/cellular network (Figure 5.5). The final elastic modulus values ranged around 2 kPa
(no significant difference amongst groups at day 21 and 35 and between days in each
group), which suggested the surfaces of semi-IPNs and semi-IPN composites were
covered by matrix and densely packed cellular network, similar to the value of adipose
tissue elastic modulus and human dermis range [59,262,263].
Like other ECM proteins, collagens are synthesized intracellularly and excreted
into pericellular regions, and later diffuse to extracellular region in vivo [264]. In highly
crosslinked hydrogel network system, diffusion of secreted collagen molecules may be
limited to the pericellular region as hydrogel mesh size is smaller than collagen (~67 nm
size for hydrated collagen fibril). Mesh size of our semi-IPNs was estimated ca. 10 nm
size, comparable to other studies [187,265,266]. At initial stage of cell culture, collagens
are deposited mainly within the pericellular region as hydrogel network structure remains
intact. As the hydrogel network degrades, free collagens diffuse to matrix region
[67,101,143,246,247,267]. However, more ECM protein deposition within semi-IPNs
and less diffusional loss would be expected. HA in semi-IPNs was degraded relatively
faster than PEGdA backbone by Hase activity and cells encapsulated within semi-IPNs
spread as early as day 3 in culture as shown in Chapter 3. Hydrophobic surfaces of PLLA
nanosphres could provide sites for ECM protein adsorption and fibril nucleation outside
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the pericellular region. No significant difference in collagen deposition between semiIPNs and semi-IPN composites up to day 21 in culture (Figure 5.7), suggesting produced
collagens were deposited mainly in pericellular region also shown as darker (blue) spots
within semi-IPNs and semi-IPN composites in Figure 5.6 even though HA enriched zone
was enzymatically degraded as early as day 3 in culture. Collagen deposition was
observed throughout the entire volume of semi-IPNs and semi-IPN composites at the end
of culture at day 35 (Figure 5.6). Especially, more collagen was deposited on the surface
of semi-IPNs and semi-IPN composites. At day 35, collagen deposition was significantly
increased in semi-IPN composites relative to semi-IPNs control and collagen deposited
within semi-IPNs control did not significantly increase after 21 days, indicating that
collagen deposition mainly occurred on the surface of PLLA nanospheres, not on
pericellular region after 21 days in culture. SEM images also confirmed matrix protein
deposition on PLLA nanospheres after 35 days in culture (Figure 5.8C through F).
Although mean size distribution of most PLLA nanosphere population ranges from 500
to 900 nm diameter, larger size PLLA partcles were spotted due to local PLLA
nanosphere aggregation by hydrophobic interaction (Figure 5.8D and E) and ECM
protein deposition on the surface of PLLA nanospheres (Figure 5.8D and F). Increased
collagen deposition within semi-IPN composites is mainly attributed to direct
accumulation of cell-secreted collagen on hydrophobic PLLA nanosphere surface. These
results suggest that the incorporation of hydrophobic PLLA nanospheres within semiIPNs support matrix protein deposition at the later stage of 3D cell culture.
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5.5 Conclusions
These studies demonstrate that through the incorporation of PLLA nanospheres
within the network, novel semi-IPN composites can provide localized hydrophobic and
stiffer surfaces that support enhanced matrix protein adsorption and promote rapid
cellular network formation relative to semi-IPNs. Newly synthesized matrix proteins
were adsorbed on hydrophobic surfaces of encapsulated PLLA nanospheres after
saturated deposition in the pericellular region. Additionally, the incorporation of
submicron-size hydrophobic polymer spheres within semi-IPNs results in less swelled
hydrogel network with significantly increased overall mechanical properties. The overall
results suggest that novel semi-IPN composites system can potentially benefit wound
healing applications with increased matrix molecule deposition.
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CHAPTER SIX
CONCLUSIONS AND FUTURE RESEARCH SUGGESTIONS

6.1 Conclusions
The ultimate goal of scaffold-based cell transplantation is to regenerate healthy
tissue at wound sites, which requires resorption/degradation of the scaffold accompanied
by new tissue formation through cell division, differentiation and matrix synthesis.
Toward this end, the overall goal of this dissertation study was to develop polyethylene
glycol diacrylate (PEGdA) / hyaluronic acid (HA) based semi-interpenetrating polymer
networks (semi-IPNs) capable of supporting 3D cell spreading, migration, differentiation,
and extracellular matrix (ECM) deposition for cell therapy applications. These studies
build upon previous work reporting the synthesis of three PEGdA macromers with
different hydrolytic degradation kinetics [188] and the ability of PEG-bis-AP with the
addition of native HA to form semi-IPNs that support encapsulated fibroblast spreading
[187].
In chapter 3, it was hypothesized that the incorporation of native HA creates
network defects by polymerization-induced phase separation that provides space for
initial Hase-mediated cell spreading and that controlled long term cellular remodeling can
be achieved by mixing of PEGdA macromers with various hydrolytic degradation rates.
First, increased gel turbidity was observed in semi-IPNs, but not in copolymerized
hydrogels containing methacrylated HA that did not support cell spreading, which
suggests an underlying mechanism of polymerization-induced phase separation resulting
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in HA-enriched defects within the network structure. These interconnected microdomains provide the space for initial cell spreading via enzymatic degradation. Thus,
PEGdA/HA semi-IPNs support two degradation mechanisms-enzymatic degradation that
is relatively fast and allows cell to assume a physiological morphology that is essential to
the function of most mesenchymally-derived cells, as well as more gradual hydrolytic
degradation to allow sustained remodeling. Through systematic optimization of network
composition, fibroblast spreading exhibited a biphasic response to HA concentration,
required a minimum HA molecular weight, decreased with increasing PEGdA
concentration, and was independent of hydrolytic degradation at early time points.
PEGdA/HA semi-IPNs were also able to support cell spreading at relatively high levels
of mechanical properties (~10 kPa elastic modulus) compared to alternative hybrid
hydrogels.

Optimized semi-IPN formulations using the blend of three PEGdA

macromers with varying susceptibility supported long-term survival of encapsulated
fibroblasts and sustained migration in a gel-within-gel encapsulation model. These results
demonstrate that PEGdA/HA semi-IPNs provide dynamic microenvironments that can
support 3D cell survival, spreading, and migration for a variety of cell transplant and
three dimensional in vitro culture applications.
In Chapter 4, it was hypothesized that the semi-IPN with optimal mechanical
properties

for

osteogenic

differentiation

could

support

prolonged

osteogenic

differentiation of mesenchymal stem cells. Selected base composition semi-IPNs fell into
optimal range for osteogenic differentiation of hMSC in 3D culture condition (10 to 30
kPa) [8]. Semi-IPNs with PEGdA blends successfully supported osteogenic
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differentiation of encapsulated hMSCs. hMSCs initially spread in HA-enriched zones
which were degraded faster by Hase and resulting spindle morphology would benefit
osteogenic differentiation because this is closer to hMSC morphology undergoing
osteogenic differentiation in vivo. Ostetogenic differentiation of encapsulated hMSCs
showed faster osteoblast maturation and similar tendency of mineralization relative to
other 2D monolayer studies [220]. Physiological calcium deposition could be observed
macroscopically as early as day 14. Hydrogels kept relatively comparable mechanical
integrity and its initial volume up to day 35, suggesting that hydrogel network was
replaced by newly generated calcified tissue with collagen, also quantitatively confirmed
by AA spectrometry. Acellular semi-IPN control result showed there was autologous
calcium deposition and culture without dexamethasone also confirmed the dependency of
osteogenic differentiation of hMSCs on dexamethasone. These results demonstrate that
PEGdA/HA semi-IPNs can support long-term osteogenic differentiation of hMSCs and
can be used as scaffolds for hard tissue (orthopaedic) engineering applications.
In Chapter 5, it was hypothesized that hydrogels have limited capacity for protein
adsorption due to their hydrophilic nature. In order to overcome this, biodegradable polyL-lactic acid (PLLA) nanospheres were incorporated within the networksto provide
hydrophobic surfaces for protein adsorption. Compared to control group (no
microspheres), higher degree of collagen deposition and more cellular network formation
inside semi-IPNs were clearly observed at day 35 in histological staining. Additionally,
the incorporation of PLLA nanospheres increased overall elastic modulus value and gel
content of semi-IPNs, and decreased equibrium water content and mass swelling ratio of
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semi-IPNs, suggesting that encapsulated hydrophobic PLLA nanospheres enhanced
polymerization process. Locally increased surface stiffness by PLLA microspheres
accommodated increased cellular spreading and accelerated network formation. These
results demonstrate that semi-IPN composites containing biodegradable hydrophobic
nanospheres provide dynamic microenvironments that can further accelerate ECM
remodeling relative to pure hydrogel scaffolds.
Overall, these studies demonstrated that PEGdA/HA semi-IPN system
successfully supported long-term cellular remodeling and its bioactivity could be further
enhanced via the incorporation of hydrophobic nanospheres. Both semi-IPNs and semiIPN composites could be used as cell transplant tissue engineering scaffold and 3D in
vitro culture system for both soft and hard tissue applications.

6.2 Future Research Suggestions
As a next step, successful in vitro culture results should be evaluated in vivo. Cells
encapsulated within semi-IPNs can be transplanted to verify degradation profile and
tissue reconstruction capability in vivo. And following studies are suggested for each
specific aims.
Aim 1: To further optimize semi-IPN composition for different target elastic
moduli values
Although semi-IPNs are fairly well optimized, it can be further tested for higher
MW of HA (more than 1.5 MDa) or higher PEGdA concentration with higher
PEGdA/HA ratios. We have already tested 6% PEGdA/HA ratios and found 6% optimal.

116

However, at higher PEGdA concentration over 8% w/v, the ratio of PEGdA/HA higher
than 6% has not been tested. Cells react differently to elastic modulus of scaffold. If
optimal composition for different PEGdA concentration (i.e. different elastic modulus
value) can be identified for corresponding target mechanical properties, the application
can be extended.
Aim 2: To expand semi-IPN application toward other stem cell
differentiation lineage and test the conjugation of bioactive molecule to enhance its
functionality
Similar semi-IPN compositions can be used for hMSC differentiation toward
chondrogenic and adipogenic differentiation in vitro. These two differentiation conditions
can easily be applied as hMSCs are capable of differentiating toward these lineages.
Ongoing studies are examining covalent conjugation of bioactive molecules such as
dexamethasone to the HA component of these networks for sequestration and cellmediated release during network remodeling. In addition, conjugating other drugs with
dexamethasone would create bilayer scaffolds that can target osteochondral defects with
two different zones, one for bone and the other for cartilage.
Aim 3: To further investigate the effect of incorporation of PLLA
nanospheres on surface roughness and gene expression, and to further enhance
bioactivity by loading bioactive growth factors within PLLA nanospheres as
delivery vehicle along with cell transplant scaffold
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3.1 Surface roughness analysis
Material surface roughness affects cell adhesion and other cellular activities
[268,269]. Although the difference observed in network formation rate on semi-IPNs and
semi-IPN composites was attributed to differences in surface stiffness, it is also possible
that changes in surface roughness may have contributed. Therefore, surface roughness
measurement (surface profile) should be done to identify the effect of PLLA nanospheres
on surface roughness.
3.2 Matrix analysis
Although changes in collagen content have been attributed to increased adsorption
to the surface of hydrophobic nanospheres resulting in improved retention within the
network, it is also possible that the changes in mechanical properties between semi-IPNs
and semi-IPN composites may also affect collagen synthesis. Therefore, it would be
beneficial to compare type I collagen transcriptional activity between cells encapsulated
within composite and control semi-IPNs to determine if this mechanism may also be
contributing to the observed results.

"3.3 Use of nanoparticle to deliver drugs/growth factors
In this dissertation study, only non-porous PLLA spheres were used for semi-IPN
composites in order to investigate the effect of inclusion of hydrophobic surface. Double
emulsion technique can be applied to include various growth factors such as TGF-β1,
vascular endothelial growth factor (VEGF), and fibroblast growth factor (FGF) in
accordance with target application for enhanced bioactivity of semi-IPN composites.
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